Search
Paclitaxel Treatment Options in Canada
A collection of 342 research studies where Paclitaxel is the interventional treatment. These studies are located in the Canada . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.
13 - 24 of 342
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
Active Not Recruiting
The purpose of this study is to assess the antitumor activity, safety, and tolerability of tislelizumab plus investigational agent(s) with or without chemotherapy. This study is structured as a master protocol with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) with high programmed cell death protein ligand-1 (PD-L1) expression (≥ 50%), and Sub-study 2 includes participants with NSCLC with low or negative (PD-L1) expression (\< 50%).
The purpose of this study is to assess the antitumor activity, safety, and tolerability of tislelizumab plus investigational agent(s) with or without chemotherapy. This study is structured as a master protocol with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) with high programmed cell death protein ligand-1 (PD-L1) expression (≥ 50%), and Sub-study 2 includes participants with NSCLC with low or negative (PD-L1) expression (\< 50%). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Valkyrie Clinical Trials, Los Angeles, California +62 locations
Valkyrie Clinical Trials, Los Angeles, California
Massachusetts General Hospital, Boston, Massachusetts
Memorial Sloan Kettering Cancer Center Mskcc, New York, New York
Providence Portland Medical Center, Portland, Oregon
Oncology and Hematology Care Clinic Westside, Portland, Oregon
The University of Texas Md Anderson Cancer Center, Houston, Texas
Blacktown Cancer and Haematology Centre, Blacktown, New South Wales
Chris Obrien Lifehouse, Camperdown, New South Wales
Northern Beaches Hospital, Frenchs Forest, New South Wales
Port Macquarie Base Hospital, Port Macquarie, New South Wales
One Clinical Research, Nedlands, Western Australia
St John of God Health Care, Subiaco, Western Australia
Hospital de Amor Barretos, Barretos, Not set
Hospital Do Cancer de Londrina, Londrina, Not set
Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Not set
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, Not set
Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, Sao Paulo, Not set
Cross Cancer Institute, Edmonton, Alberta
The Second Hospital of Anhui Medical University, Hefei, Anhui
The Fifth Medical Center of Chinese Pla General Hospital, Beijing, Beijing
Fujian Cancer Hospital, Fuzhou, Fujian
Affiliated Hospital of Hebei University, Baoding, Hebei
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Henan Cancer Hospital, Zhengzhou, Henan
Hubei Cancer Hospital, Wuhan, Hubei
Nantong Tumor Hospital Branch North, Nantong, Jiangsu
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
The First Affiliated Hospital of Nanchang University Branch Xianghu, Nanchang, Jiangxi
Jining No Peoples Hospital East Branch, Jining, Shandong
Linyi Peoples Hospital, Linyi, Shandong
Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai
Shanghai East Hospital Branch Hospital, Shanghai, Shanghai
Shanghai Pulmonary Hospital, Shanghai, Shanghai
Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
Taizhou Hospital of Zhejiang, Taizhou, Zhejiang
Institut Curie, Paris, Not set
Chu Nantes Hopital Nord Laennec, SaintHerblain, Not set
Arensia Exploratory Medicine Llc, Tbilisi, Not set
Regina Elena, Istituto Nazionale Dei Tumori, Ifo, Irccs, Roma, Not set
Centro Ricerche Cliniche Di Verona, Verona, Not set
Chungbuk National University Hospital, SeowonGu CheongjuSi, Chungcheongbukdo
Seoul National University Bundang Hospital, BundangGu SeongnamSi, Gyeonggi-do
National Cancer Center (Korea), IlsandongGu GoyangSi, Gyeonggi-do
The Catholic University of Korea, St Vincents Hospital, PaldalGu SuwonSi, Gyeonggi-do
Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi
Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi
Asan Medical Center, SongpaGu, Seoul Teugbyeolsi
Pulau Pinang Hospital, Georgetown, Not set
Sultan Ismail Hospital, Johor Bahru, Not set
Tengku Ampuan Afzan Hospital, Kuantan, Not set
Sarawak General Hospital, Kuching, Not set
The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Not set
Institute of Oncology Bucharest Prof Dr Alexandru Trestioreanu, Bucureti, Not set
Arensia Research Clinic At the Oncology Institute Prof Dr Ion Chiricu, ClujNapoca, Not set
National Cancer Centre Singapore, Singapore, Not set
Hospital Universitario Vall Dhebron, Barcelona, Not set
Hospital Universitario de Octubre, Madrid, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Songklanagarind Hospital (Prince of Songkhla University), Hat Yai, Not set
Srinagarind Hospital (Khon Kaen University), Muang, Not set
Maharaj Nakorn Chiang Mai Hospital (Chiang Mai University), Muang, Not set
Hrh Princess Maha Chakri Sirindhorn Medical Center (Srinakharinwirot University), Ongkharak, Not set
Conditions: Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Active Not Recruiting
This phase II trial studies the side effects of bevacizumab and anetumab ravtansine or paclitaxel in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that does not respond to treatment (refractory). Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Anetumab ravtansine is a drug that targets a protein in the body called mesothelin, which can be found in some ovarian, pancreatic and other tumors. Chemotherapy dru... Read More
This phase II trial studies the side effects of bevacizumab and anetumab ravtansine or paclitaxel in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that does not respond to treatment (refractory). Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Anetumab ravtansine is a drug that targets a protein in the body called mesothelin, which can be found in some ovarian, pancreatic and other tumors. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving bevacizumab and anetumab ravtansine or paclitaxel may work better in treating patients with ovarian, fallopian tube, or primary peritoneal cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California +22 locations
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
UCHealth University of Colorado Hospital, Aurora, Colorado
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida
Moffitt Cancer Center, Tampa, Florida
Northwestern University, Chicago, Illinois
HaysMed, Hays, Kansas
The University of Kansas Cancer Center - Olathe, Olathe, Kansas
Mercy Hospital Pittsburg, Pittsburg, Kansas
Salina Regional Health Center, Salina, Kansas
University of Kansas Health System Saint Francis Campus, Topeka, Kansas
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Weisberg Cancer Treatment Center, Farmington Hills, Michigan
Washington University School of Medicine, Saint Louis, Missouri
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
University of Virginia Cancer Center, Charlottesville, Virginia
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Conditions: Fallopian Tube Endometrioid Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma, Primary Peritoneal High Grade Serous Adenocarcinoma, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian High Grade Serous Adenocarcinoma
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recruiting
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by blinded independent central review (BICR).
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by blinded independent central review (BICR). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock, Arkansas +219 locations
UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock, Arkansas
Highlands Oncology Group-Research Department ( Site 0062), Springdale, Arkansas
Beverly Hills Cancer Center ( Site 0070), Beverly Hills, California
The Angeles Clinic and Research Institute ( Site 0040), Los Angeles, California
The Angeles Clinic and Research Institute- A Cedars-Sinai Affiliate ( Site 0079), Los Angeles, California
San Francisco Oncology Associates ( Site 0066), San Francisco, California
Stamford Hospital ( Site 0083), Stamford, Connecticut
Mount Sinai Cancer Center ( Site 0038), Miami Beach, Florida
Mid Florida Hematology and Oncology Center ( Site 0018), Orange City, Florida
Emory University School of Medicine-Phase I ( Site 0056), Atlanta, Georgia
Northside Hospital ( Site 0055), Atlanta, Georgia
Centricity Research Columbus Cancer Center ( Site 0005), Columbus, Georgia
Lewis Cancer and Research Pavilion ( Site 0063), Savannah, Georgia
Archbold Cancer Center ( Site 0071), Thomasville, Georgia
Edward-Elmhurst Healthcare, Elmhurst Hospital-Nancy W. Knowles Cancer Center ( Site 0017), Elmhurst, Illinois
Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Center ( Site 0078), Naperville, Illinois
Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne, Indiana
Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette, Indiana
Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood, Kentucky
Our Lady of the Lake Physician Group-Medical Oncology ( Site 0080), Baton Rouge, Louisiana
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0027), Minneapolis, Minnesota
Mercy Research - David C. Pratt Cancer Center ( Site 0006), Saint Louis, Missouri
Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0037), Reno, Nevada
Atlantic Health Morristown Medical Center ( Site 0077), Morristown, New Jersey
Stony Brook University-Cancer Center ( Site 0054), Stony Brook, New York
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo, North Dakota
Oregon Health and Science University ( Site 0052), Portland, Oregon
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster, Pennsylvania
Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston, South Carolina
Sanford Cancer Center ( Site 0053), Sioux Falls, South Dakota
Avera Cancer Institute- Research ( Site 0090), Sioux Falls, South Dakota
University of Tennessee Medical Center Knoxville ( Site 0082), Knoxville, Tennessee
Millennium Research & Clinical Development ( Site 0039), Houston, Texas
Huntsman Cancer Institute ( Site 0042), Salt Lake City, Utah
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0213), Ciudad Autonoma de Buenos Aires, Buenos Aires
Hospital Británico de Buenos Aires-Oncology ( Site 0207), Ciudad autónoma de Buenos Aires, Buenos Aires
Sanatorio Británico-Clinical Oncology Department ( Site 0206), Rosario, Santa Fe
Sanatorio Parque ( Site 0205), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0202), Buenos Aires, Not set
Hospital Privado Universitario de Córdoba-Hematology and Oncology ( Site 0204), Cordoba, Not set
Westmead Hospital ( Site 0701), Westmead, New South Wales
The Prince Charles Hospital ( Site 0700), Brisbane, Queensland
Fiona Stanley Hospital-Medical Oncology ( Site 0705), Murdoch, Western Australia
Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 1402), Linz, Oberosterreich
Medizinische Universitaet Innsbruck-Department for Internal Medicine V ( Site 1403), Innsbruck, Tirol
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 1400), Wien, Not set
Antwerp University Hospital-Thoracic Oncology ( Site 1503), Edegem, Antwerpen
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 1502), Yvoir, Namur
VITAZ ( Site 1500), Sint-Niklaas, Oost-Vlaanderen
Liga Norte Riograndense Contra o Câncer ( Site 0301), Natal., Rio Grande Do Norte
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0303), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 0302), Porto Alegre, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 0319), Santa Cruz do Sul, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0304), Barretos, Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0313), São José do Rio Preto, Sao Paulo
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0100), Greenfield Park, Quebec
St. Marys Hospital Center ( Site 0107), Montreal, Quebec
Centre Hospitalier de l'Université de Montréal ( Site 0104), Montréal, Quebec
FALP-UIDO ( Site 0401), Providencia, Region M. De Santiago
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0404), Santiago., Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0400), Santiago, Region M. De Santiago
ONCOCENTRO APYS-ACEREY ( Site 0410), Viña del Mar, Valparaiso
Beijing Cancer hospital-Thoracic Surgery department I ( Site 1301), Beijing, Beijing
Beijing Peking Union Medical College Hospital-Thoracic surgery department ( Site 1302), Beijing, Beijing
Peking University People's Hospital. ( Site 1300), Beijing, Beijing
Fujian Cancer Hospital-oncology department ( Site 1314), Fuzhou, Fujian
The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 1320), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Thoracic surgery department ( Site 1313), Guangzhou, Guangdong
Henan Cancer Hospital-henan cancer hospital ( Site 1316), Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technology-Thoracic Surgery ( Site 1306), Wuhan, Hubei
Hubei Cancer Hospital ( Site 1308), Wuhan, Hubei
Xiangya Hospital Central South University-Thoracic surgery ( Site 1311), Changsha, Hunan
Hunan Cancer Hospital ( Site 1312), Changsha, Hunan
Nanjing First Hospital ( Site 1310), Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University-Thoracic Surgery Department ( Site 1318), Suzhou, Jiangsu
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 1330), Nanchang, Jiangxi
The First Hospital of Jilin University ( Site 1324), Changchun, Jilin
The Second Affiliated Hospital of Air Force Medical University ( Site 1332), Xian, Shaanxi
Shandong Cancer Hospital ( Site 1321), Jinan, Shandong
Zhongshan Hospital Fudan University ( Site 1325), Shangai, Shanghai
Shanghai Pulmonary Hospital-Thoracic Surgery department ( Site 1304), Shanghai, Shanghai
Sichuan Cancer hospital. ( Site 1327), Chengdu, Sichuan
The Second People's Hospital of Neijiang ( Site 1322), Neijiang, Sichuan
Yunnan Province Cancer Hospital ( Site 1315), Kunming, Yunnan
The first Affiliated Hospital, Zhejiang University School of-Thoracic Cardiovascular Surgery Ward ( Site 1303), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 1309), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 1328), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province ( Site 1329), Linhai, Zhejiang
Ningbo No. 2 Hospital ( Site 1305), Ningbo, Zhejiang
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 1600), Brno, Brno-mesto
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1601), Ostrava, Ostrava Mesto
CHRU de Brest ( Site 1804), Brest, Finistere
CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 1801), Toulouse, Haute-Garonne
CHU Charles Nicolle ( Site 1803), Rouen, Haute-Normandie
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1805), Limoges, Haute-Vienne
Groupe hospitalier Paris saint Joseph. ( Site 1807), Paris, Ile-de-France
Clinique Teissier Groupe ( Site 1811), Valenciennes, Nord
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1810), Clermont-Ferrand, Puy-de-Dome
Hospices Civils de Lyon - Hopital Louis Pradel ( Site 1809), Bron, Rhone
HIA Sainte Anne ( Site 1800), Toulon, Var
Hôpital Tenon ( Site 1802), Paris, Not set
Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1914), Esslingen, Baden-Wurttemberg
Katholisches Klinikum Koblenz ( Site 1911), Koblenz, Rheinland-Pfalz
Krankenhaus Martha-Maria Halle-Dölau-Klinik für Innere Medizin II ( Site 1908), Halle, Sachsen-Anhalt
Universitätsklinikum Leipzig ( Site 1915), Leipzig, Sachsen
SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1900), Gera, Thuringen
Vivantes Hospital Spandau-Klinik für Innere Medizin, Hämatologie, Onkologie und Gastroenterologie- ( Site 1912), Berlin, Not set
Helios Klinikum Emil von Behring Berlin-Zehlendorf ( Site 1916), Berlin, Not set
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 2006), Patras, Achaia
251 Hellenic Air Force General Hospital ( Site 2003), Athens, Attiki
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 2000), Athens, Attiki
Athens Medical Center ( Site 2005), Athens, Attiki
Metaxa Cancer Hospital of Piraeus ( Site 2002), Piraeus, Attiki
University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 2001), Heraklion, Irakleio
University General Hospital of Larissa-Oncology Clinic ( Site 2004), Larissa, Thessalia
European Interbalkan Medical Center ( Site 2007), Thessaloniki, Not set
Queen Mary Hospital ( Site 3400), Hksar, Not set
Hong Kong United Oncology Centre ( Site 3403), Kowloon, Not set
Queen Elizabeth Hospital ( Site 3402), Yau Ma Tei, Not set
Rambam Health Care Campus-Oncology Division ( Site 2203), Haifa, Not set
Shaare Zedek Medical Center ( Site 2206), Jerusalem, Not set
Rabin Medical Center ( Site 2204), Petah Tikva, Not set
Sheba Medical Center ( Site 2200), Ramat Gan, Not set
Humanitas Istituto Clinico Catanese ( Site 2315), Misterbianco, Catania
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 2302), Meldola, Emilia-Romagna
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 2300), Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori-Oncologia ( Site 2301), Monza, Lombardia
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 2309), Rome, Roma
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 2307), Firenze, Toscana
Humanitas Gavazzeni-ONCOLOGY ( Site 2310), Bergamo, Not set
Ospedale San Martino ( Site 2313), Genova, Not set
Ospedale San Raffaele-Oncologia Medica ( Site 2311), Milano, Not set
Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 2312), Parma, Not set
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 2303), Pavia, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 2306), Roma, Not set
APSS- Presidio Ospedaliero S. Chiara ( Site 2304), Trento, Not set
National Hospital Organization Shikoku Cancer Center ( Site 1216), Matsuyama, Ehime
Hospital of the University of Occupational and Environmental Health, Japan ( Site 1217), Kitakyushu, Fukuoka
Kobe City Medical Center General Hospital ( Site 1213), Kobe, Hyogo
St. Marianna University Hospital ( Site 1207), Kawasaki, Kanagawa
Kanagawa Cancer Center ( Site 1206), Yokohama, Kanagawa
Kansai Medical University Hospital ( Site 1211), Hirakata, Osaka
Kindai University Hospital ( Site 1212), Osakasayama, Osaka
Saitama Prefectural Cancer Center ( Site 1201), Kitaadachi-gun, Saitama
Juntendo University Hospital ( Site 1204), Bunkyo-ku, Tokyo
Tokyo Medical University Hospital ( Site 1203), Shinjuku, Tokyo
National Hospital Organization Kyushu Cancer Center ( Site 1218), Fukuoka, Not set
Fukushima Medical University Hospital ( Site 1200), Fukushima, Not set
Hiroshima University Hospital ( Site 1215), Hiroshima, Not set
Niigata Cancer Center Hospital ( Site 1208), Niigata, Not set
Okayama University Hospital ( Site 1214), Okayama, Not set
Osaka International Cancer Institute ( Site 1210), Osaka, Not set
Nippon Medical School Hospital ( Site 1205), Tokyo, Not set
Chungbuk National University Hospital-Internal medicine ( Site 1000), Cheongju-si, Chungbuk
National Cancer Center-Lung Cancer Center ( Site 1002), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital-Medical Oncology ( Site 1003), Seongnam, Kyonggi-do
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 1001), Suwon-si, Kyonggi-do
Keimyung University Dongsan Hospital CRC room 1 ( Site 1006), Daegu, Taegu-Kwangyokshi
Asan Medical Center-Lung Cancer Center ( Site 1005), Seoul, Not set
Samsung Medical Center-Division of Hematology/Oncology ( Site 1004), Seoul, Not set
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0506), Guadalajara, Jalisco
Centro de Investigacion Clinica de Oaxaca ( Site 0509), Oaxaca de Juarez, Oaxaca
Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0504), Chihuahua, Not set
Mediadvance Clinical ( Site 0502), Chihuahua, Not set
Oaxaca Site Management Organization S.C. ( Site 0507), Oaxaca, Not set
Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 3453), Breda, Noord-Brabant
Isala, locatie Zwolle-Poli Longziekten ( Site 3454), Zwolle, Overijssel
Meander Medisch Centrum-Researchbureau Longgeneeskunde ( Site 3458), Amersfoort, Utrecht
Erasmus Medisch Centrum ( Site 3452), Rotterdam, Zuid-Holland
University Medical Center Groningen ( Site 3459), Groningen, Not set
Sint Antonius Ziekenhuis ( Site 3455), Utrecht, Not set
Auckland City Hospital ( Site 0800), Auckland, Not set
Akershus Universitetssykehus ( Site 2501), Lørenskog, Akershus
Drammen Sykehus, Vestre Viken HF ( Site 2502), Drammen, Buskerud
Sykehuset Innlandet HF Gjøvik ( Site 2503), Gjøvik, Oppland
Oslo universitetssykehus HF. Radiumhospitalet ( Site 2504), Oslo, Not set
IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0604), Lima, Not set
Oncosalud ( Site 0602), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 0600), Lima, Not set
Instituto Neuro Cardiovascular de las Americas ( Site 0607), Lima, Not set
Hospital Nacional Edgardo Rebagliati Martins-medical oncology ( Site 0603), Lima, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2600), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2601), Przemysl, Podkarpackie
Bialostockie Centrum Onkologii ( Site 2604), Bialystok, Podlaskie
Uniwersyteckie Centrum Kliniczne ( Site 2610), Gdansk, Pomorskie
Szpital Specjalistyczny w Prabutach Spolka z o.o. ( Site 2613), Prabuty, Pomorskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2606), Olsztyn, Warminsko-mazurskie
Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2602), Poznan, Wielkopolskie
UNIDADE LOCAL DE SAUDE DE MATOSINHOS-Serviço de Oncologia ( Site 2705), Matosinhos, Porto
Instituto Portugês de Oncologia de Coimbra Francisco Gentil-Oncologia Médica ( Site 2704), Coimbra, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702), Porto, Not set
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L.. ( Site 2803), Bucharest, Bucuresti
Spitalul Universitar de Urgență Elias ( Site 2804), București, Bucuresti
Cardiomed SRL Cluj-Napoca-Medical Oncology ( Site 2801), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2802), Florești, Cluj
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2805), Craiova, Dolj
SC ONCO CARD SRL ( Site 2808), Brasov, Not set
Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2901), L Hospitalet, Barcelona
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2905), Santiago de Compostela, La Coruna
Hospital Insular de Gran Canaria-Oncology ( Site 2903), Las Palmas de Gran Canaria, Las Palmas
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2902), Pozuelo de Alarcon, Madrid
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2900), Barcelona, Not set
Hospital Clinico San Carlos-Oncology Department ( Site 2904), Madrid, Not set
Kantonsspital Graubünden-Medizin ( Site 3006), Chur, Grisons
Kantonsspital Münsterlingen - Spital Thurgau AG ( Site 3005), Munsterlingen, Thurgau
CHUV (centre hospitalier universitaire vaudois) ( Site 3003), Lausanne, Vaud
HFR Fribourg - Hôpital Cantonal ( Site 3004), Fribourg, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 1105), Taipei City, Taipei
Tri-Service General Hospital ( Site 1100), Taipei City, Taipei
Taoyuan General Hospital ( Site 1106), Taoyuan City, Taoyuan
Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 1103), Kaohsiung, Not set
Taichung Veterans General Hospital-Chest ( Site 1101), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 1102), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 1104), Taipei, Not set
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 3106), Adana, Not set
Gulhane Egitim Arastirma Hastanesi-Onkoloji ( Site 3104), Ankara, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 3101), Ankara, Not set
Memorial Ankara Hastanesi-Medical Oncology ( Site 3110), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 3103), Ankara, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 3107), Istanbul, Not set
Conditions: Non Small Cell Lung Cancer
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
Recruiting
This study will compare how safe and effective sacituzumab tirumotecan is versus the treatment of physician's choice (TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumotecan is superior to TPC with respect to Overall Survival (OS).
This study will compare how safe and effective sacituzumab tirumotecan is versus the treatment of physician's choice (TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumotecan is superior to TPC with respect to Overall Survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: Banner MD Anderson Cancer Center ( Site 0119), Gilbert, Arizona +165 locations
Banner MD Anderson Cancer Center ( Site 0119), Gilbert, Arizona
UCLA Hematology/Oncology - Santa Monica ( Site 0140), Los Angeles, California
AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0129), Orlando, Florida
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0108), Marietta, Georgia
University of Chicago Medical Center ( Site 0120), Chicago, Illinois
University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0124), Lexington, Kentucky
The University of Louisville, James Graham Brown Cancer Center-James Graham Brown Cancer Center ( Site 0113), Louisville, Kentucky
Norton Audubon Hospital-Norton Cancer Institute - Audubon ( Site 0105), Louisville, Kentucky
Henry Ford Hospital ( Site 0107), Detroit, Michigan
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0138), Fargo, North Dakota
Oregon Health and Science University ( Site 0104), Portland, Oregon
UPMC Hillman Cancer Center ( Site 0126), Pittsburgh, Pennsylvania
MUSC Hollings Cancer Center-Hematology Oncology ( Site 0122), Charleston, South Carolina
Sanford Cancer Center ( Site 0136), Sioux Falls, South Dakota
The West Clinic, PLLC dba West Cancer Center ( Site 0110), Germantown, Tennessee
Inova Schar Cancer ( Site 0106), Fairfax, Virginia
Fred Hutchinson Cancer Center ( Site 0111), Seattle, Washington
Institut Jules Bordet-GastroIntestinal Medical Oncology ( Site 1003), Anderlecht, Bruxelles-Capitale, Region De
Cliniques universitaires Saint-Luc-Medical Oncology ( Site 1001), Bruxelles, Bruxelles-Capitale, Region De
UZ Leuven-Digestive Oncology ( Site 1000), Leuven, Vlaams-Brabant
AZ Delta vzw ( Site 1002), Roeselare, West-Vlaanderen
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará ( Site 0405), Fortaleza, Ceara
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0406), Natal, Rio Grande Do Norte
Hospital de Caridade de Ijuí ( Site 0412), Ijui, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 0400), Porto Alegre, Rio Grande Do Sul
Centro de Hematologia e Oncologia ( Site 0404), Joinville, Santa Catarina
Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0401), Barretos., Sao Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0411), São José do Rio Preto, Sao Paulo
A. C. Camargo Cancer Center ( Site 0409), Sao Paulo, Not set
IBCC - Núcleo de Pesquisa e Ensino ( Site 0402), Sao Paulo, Not set
McGill University Health Centre ( Site 0201), Montréal, Quebec
James Lind Centro de Investigacion del Cancer ( Site 0506), Temuco, Araucania
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0503), Santiago., Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0501), Santiago., Region M. De Santiago
FALP-UIDO ( Site 0500), Santiago, Region M. De Santiago
Clínica UC San Carlos de Apoquindo-Hemato-Oncology ( Site 0502), Santiago, Region M. De Santiago
Anhui Provincial Cancer Hospital-medical oncology ( Site 3016), Hefei, Anhui
Second Affiliated hospital of Anhui Medical University-Oncology ( Site 3038), Hefei, Anhui
Chongqing University Three Gorges Hospital ( Site 3036), Chongqing, Chongqing
Fujian Cancer Hospital ( Site 3007), Fuzhou, Fujian
The 900th Hospital of the Joint Logistics Support Force of PLA ( Site 3008), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-oncology ( Site 3011), Xiamen, Fujian
Zhongshan Hospital Affiliated to Xiamen University ( Site 3013), Xiamen, Fujian
Southern Medical University Nanfang Hospital-Department of Oncology ( Site 3019), Guangzhou, Guangdong
Sun Yatsen University Cancer Center ( Site 3001), Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College ( Site 3034), Shantou, Guangdong
Affiliated Cancer Hospital of Guangxi Medical University ( Site 3047), Nanning, Guangxi
Fourth Hospital of Hebei Medical University ( Site 3015), Shijiazhuang, Hebei
Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital ( Site 3005), Harbin, Heilongjiang
Henan Cancer Hospital-henan cancer hospital ( Site 3002), Zhengzhou, Henan
Hubei Cancer Hospital ( Site 3012), Wuhan, Hubei
Xiangyang Central Hospital ( Site 3045), Xiangyang, Hubei
Hunan Cancer Hospital ( Site 3014), Changsha, Hunan
The First Affiliated Hospital of Soochow University ( Site 3040), Suzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 3037), Nanchang, Jiangxi
Jilin Province Tumor Hospital ( Site 3018), Changchun, Jilin
LinYi Cancer Hospital-Gastrology department ( Site 3024), Linyi, Shandong
Renji Hosp,Shanghai Jiao Tong University School of Medicine ( Site 3042), Shangai, Shanghai
Fudan University Shanghai Cancer Center-medical oncology ( Site 3009), Shanghai, Shanghai
Zhongshan Hospital,Fudan University-Oncology ( Site 3003), Shanghai, Shanghai
West China Hospital, Sichuan University ( Site 3035), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 3030), Chengdu, Sichuan
Nanchong Central Hospital (Jiangdong Campus) ( Site 3029), Nanchong, Sichuan
Xinjiang Medical University Cancer Hospital - Urumchi-The No.11 of Surgery building ( Site 3010), Urumchi, Xinjiang
Yunnan Province Cancer Hospital ( Site 3031), Kunming, Yunnan
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-Oncology ( Site 3006), Hangzhou, Zhejiang
Zhejiang Cancer Hospital-Oncology ( Site 3021), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province ( Site 3020), Linhai, Zhejiang
Yueqing People's Hospital ( Site 3041), Yueqing, Zhejiang
Centro Cancerológico del Caribe (CECAC) ( Site 0606), Barranquilla, Atlantico
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0600), Valledupar, Cesar
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0602), Bogota, Distrito Capital De Bogota
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0603), Bogota, Distrito Capital De Bogota
Fundación Valle del Lili-Fundacion Valle del Lili ( Site 0607), Cali, Valle Del Cauca
Rigshospitalet ( Site 1102), Copenhagen, Hovedstaden
Aalborg Universitetshospital, Syd-Department of Oncology ( Site 1103), Aalborg, Nordjylland
Odense Universitetshospital-Department of oncology ( Site 1101), Odense, Syddanmark
Institut Bergonié - Centre Régional de Lutte Contre Le Cance-Medical Oncology ( Site 1211), Bordeaux, Aquitaine
Centre François Baclesse ( Site 1202), Caen, Calvados
CHU Rangueil-Digestive oncology department ( Site 1210), Toulouse, Haute-Garonne
Institut Mutualiste Montsouris-Oncology ( Site 1216), Paris, Ile-de-France
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 1203), Rennes, Ille-et-Vilaine
Centre Oscar Lambret ( Site 1206), Lille, Nord-Pas-de-Calais
CENTRE LEON BERARD-Medical oncology ( Site 1208), Lyon, Rhone-Alpes
Centre Hospitalier Universitaire de Poitiers ( Site 1209), Poitiers, Vienne
Hôpital Saint-Louis ( Site 1201), Paris, Not set
NCT-Department of Medical Oncology ( Site 1302), Heidelberg, Baden-Wurttemberg
Universitätsmedizin Göttingen - Georg-August-Universität ( Site 1310), Goettingen, Niedersachsen
Universitaetsklinikum Carl Gustav Carus Dresden-Medical Dept I - Medical Oncology ( Site 1307), Dresden, Sachsen
Städtisches Krankenhaus Kiel-2. Medizinische Klinik ( Site 1306), Kiel, Schleswig-Holstein
Charité Campus Virchow-Klinikum-Klinik Hämatologie Onkologie Tumorimmunologie ( Site 1304), Berlin, Not set
Facharztzentrum Eppendorf-Facharztzentrum Eppendorf ( Site 1300), Hamburg, Not set
Queen Mary Hospital ( Site 3100), Hong Kong, Not set
Prince of Wales Hospital ( Site 3102), Shatin, Not set
Queen Elizabeth Hospital ( Site 3101), Yau Ma Tei, Not set
Hillel Yaffe Medical Center ( Site 1604), Hadera, Not set
Rambam Health Care Campus-Oncology Division ( Site 1600), Haifa, Not set
Hadassah Medical Center ( Site 1603), Jerusalem, Not set
Rabin Medical Center ( Site 1605), Petah Tikva, Not set
Sourasky Medical Center ( Site 1602), Tel Aviv, Not set
Azienda Ospedaliera Universitaria dell'Università "Luigi Van-UOC Oncoematologia ( Site 1704), Napoli, Campania
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1703), Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1700), Milan, Lombardia
Azienda Ospedaliero Universitaria Pisana ( Site 1702), Pisa, Toscana
Ospedale San Raffaele-Oncologia Medica ( Site 1701), Milano, Not set
Aichi Cancer Center ( Site 3307), Nagoya, Aichi
National Cancer Center Hospital East ( Site 3300), Kashiwa, Chiba
Kochi Medical School Hospital ( Site 3304), Nankoku, Kochi
Saitama Prefectural Cancer Center ( Site 3302), Kitaadachi-gun, Saitama
National Cancer Center Hospital ( Site 3301), Chuo, Tokyo
Cancer Institute Hospital of JFCR ( Site 3306), Koto, Tokyo
National Hospital Organization Kyushu Cancer Center ( Site 3303), Fukuoka, Not set
Osaka International Cancer Institute ( Site 3305), Osaka, Not set
Seoul National University Bundang Hospital ( Site 3504), Seongnam, Kyonggi-do
Seoul National University Hospital-Oncology ( Site 3503), Seoul, Not set
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3500), Seoul, Not set
Asan Medical Center-Department of Oncology ( Site 3501), Seoul, Not set
Samsung Medical Center-Division of Hematology/Oncology ( Site 3502), Seoul, Not set
The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 3505), Seoul, Not set
Hospital Pulau Pinang ( Site 3403), George Town, Pulau Pinang
Sarawak General Hospital-Radiotherapy Unit ( Site 3401), Kuching, Sarawak
National Cancer Institute-Radiotherapy and Oncology ( Site 3404), Putrajaya, Wilayah Persekutuan Putrajaya
University Malaya Medical Centre-Clinical Oncology ( Site 3402), Kuala Lumpur, Not set
Pantai Hospital Kuala Lumpur-Cancer Centre ( Site 3408), Kuala Lumpur, Not set
COI Centro Oncologico Internacional S.A.P.I. de C.V.-Investigation Unit COI ( Site 0802), Mexico City, Distrito Federal
CANCER TREAMTENT CLINIC AND CLINICAL TRIALS SA DE CV ( Site 0814), Guadalajara, Jalisco
Centro de Investigacion Clinica de Oaxaca ( Site 0810), Oaxaca de Juarez, Oaxaca
Centro Potosino de Investigación Médica ( Site 0801), San Luis Potosí, San Luis Potosi
Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 0904), Concepcion, Junin
Hospital de Alta Complejidad La Libertad-Unidad de Investigación en Oncología ( Site 0902), Trujillo, La Libertad
Clínicas AUNA Sede Chiclayo ( Site 0907), Chiclayo, Lambayeque
Clínica Internacional - Sede San Borja ( Site 0906), Lima, Not set
IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0905), Lima, Not set
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 0900), Lima, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1807), Bydgoszcz, Kujawsko-pomorskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Onkologii i Radioterapii ( Site 1800), Warszawa, Mazowieckie
Bialostockie Centrum Onkologii ( Site 1804), Bialystok, Podlaskie
Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej " Profil Jednego Dnia " ( Site 1810), Gdynia, Pomorskie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 1811), Kielce, Swietokrzyskie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1801), Koszalin, Zachodniopomorskie
Hospital Universitario Central de Asturias-Medical Oncology ( Site 1902), Oviedo, Asturias
Hospital Universitario Marqués de Valdecilla ( Site 1901), Santander, Cantabria
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1905), A Coruna, La Coruna
COMPLEJO HOSPITALARIO DE NAVARRA-Medical Oncology ( Site 1904), Pamplona, Navarra
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1900), Barcelona, Not set
Hospital Clinico San Carlos ( Site 1903), Madrid, Not set
China Medical University Hospital ( Site 3603), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 3604), Tainan, Not set
National Taiwan University Hospital ( Site 3600), Taipei, Not set
Taipei Veterans General Hospital ( Site 3601), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch ( Site 3602), Taoyuan, Not set
Chulalongkorn University ( Site 3702), Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital ( Site 3700), Bangkok, Krung Thep Maha Nakhon
Songklanagarind hospital ( Site 3701), HatYai, Songkhla
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 2104), Adana, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2100), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2101), Ankara, Not set
Dicle Üniversitesi-oncology ( Site 2108), Diyarbakir, Not set
Atatürk Üniversitesi-onkoloji ( Site 2111), Erzurum, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2106), Istanbul, Not set
Samsun Medical Park Hastanesi-medical oncology ( Site 2110), Samsun, Not set
Yuzuncu Yil University Dursun Odaba Tp Merkezi-Medical Oncology ( Site 2109), Van, Not set
Addenbrooke's Hospital ( Site 2203), Cambridge, Cambridgeshire
Ninewells Hospital and Medical School-Oncology Petty ( Site 2209), Dundee, Dundee City
St Bartholomew's Hospital ( Site 2206), London, London, City Of
The Christie NHS Foundation Trust-Medical Oncology ( Site 2201), Manchester, Not set
Conditions: Gastroesophageal Cancer
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Recruiting
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS).
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: CARTI Cancer Center ( Site 0006), Little Rock, Arkansas +188 locations
CARTI Cancer Center ( Site 0006), Little Rock, Arkansas
Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0122), Burbank, California
Exempla Lutheran Medical Center ( Site 0119), Golden, Colorado
Intermountain Health St. Mary's Regional Hospital ( Site 0116), Grand Junction, Colorado
Mid Florida Hematology and Oncology Center ( Site 0109), Orange City, Florida
Centricity Research Columbus Cancer Center ( Site 0111), Columbus, Georgia
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0001), Marietta, Georgia
University of Chicago Medical Center ( Site 0145), Chicago, Illinois
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0146), Minneapolis, Minnesota
New Mexico Oncology Hematology Consultants Ltd. ( Site 0123), Albuquerque, New Mexico
Thomas Jefferson University - Clinical Research Institute ( Site 0147), Philadelphia, Pennsylvania
Oncology Consultants P.A. ( Site 0124), Houston, Texas
Mays Cancer Center ( Site 0132), San Antonio, Texas
Instituto Alexander Fleming ( Site 0203), Ciudad Autónoma de Buenos Aires, Buenos Aires
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0200), Mar del Plata, Buenos Aires
Instituto Médico Río Cuarto ( Site 0204), Rio Cuarto., Cordoba
Fundacion Intecnus ( Site 0205), San Carlos de Bariloche, Rio Negro
Sanatorio Parque ( Site 0201), Rosario, Santa Fe
Hospital Aleman-Oncology ( Site 0202), Buenos Aires, Not set
Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 0720), Linz, Oberosterreich
Klinik Hietzing ( Site 0740), Wien, Not set
Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 0730), Wien, Not set
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 0710), Wien, Not set
Hospital de Câncer de Recife ( Site 0312), Recife, Pernambuco
Oncoclínica Oncologistas Associados ( Site 0309), Terezina, Piaui
Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0311), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceição ( Site 0300), Porto Alegre, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 0304), Santa Cruz do Sul, Rio Grande Do Sul
Hospital de Base de São José do Rio Preto ( Site 0310), São José do Rio Preto, Sao Paulo
Hospital Paulistano ( Site 0307), Sao Paulo, Not set
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0100), Kingston, Ontario
Waterloo Regional Health Network (WRHN) ( Site 0153), Kitchener, Ontario
St. Marys Hospital Center ( Site 0105), Montreal, Quebec
McGill University Health Centre ( Site 0103), Montréal, Quebec
Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0106), Trois-Rivières, Quebec
Centro de Investigación del Maule ( Site 0419), Talca, Maule
FALP ( Site 0409), Santiago, Region M. De Santiago
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0402), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 0407), Santiago, Region M. De Santiago
ONCOCENTRO APYS-ACEREY ( Site 0400), Viña del Mar, Valparaiso
Bradford Hill Norte ( Site 0420), Antofagasta, Not set
Beijing Cancer Hospital ( Site 2411), Beijing, Beijing
Beijing Cancer hospital-intrathoratic deparmtment II ( Site 2410), Beijing, Beijing
Peking Union Medical College Hospital ( Site 2412), Beijing, Beijing
Army Medical Center of People's Liberation Army-respiratory ( Site 2426), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 2419), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University-oncology ( Site 2420), Xiamen, Fujian
The First Affiliated Hospital of Guangzhou Medical University ( Site 2417), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 2416), Guangzhou, Guangdong
Harbin Medical University Cancer Hospital-oncology of department ( Site 2415), Harbin, Heilongjiang
Henan Cancer Hospital-Pneumology department ( Site 2423), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology ( Site 2424), Wuhan, Hubei
The Second Xiangya Hospital of Central South University-Oncology ( Site 2418), Changsha, Hunan
First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 2402), Huai'an, Jiangsu
Northern Jiangsu People's Hospital-General Surgery Department ( Site 2403), Yangzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University-Oncology Department ( Site 2405), Nanchang, Jiangxi
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 2404), Nanchang, Jiangxi
Jilin Province Tumor Hospital-GCP office ( Site 2413), Changchun, Jilin
The First Hospital of Jilin University-Oncology ( Site 2414), Changchun, Jilin
Shanghai East Hospital ( Site 2428), Shanghai, Shanghai
Shanghai Pulmonary Hospital ( Site 2427), Shanghai, Shanghai
West China Hospital, Sichuan University ( Site 2422), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 2421), Chengdu, Sichuan
The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 2425), Urumqi, Xinjiang
The first Affiliated Hospital, Zhejiang University School of Medicine-Respiratory Department ( Site 2406), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-Medical Oncology ( Site 2407), Hangzhou, Zhejiang
Zhejiang Cancer Hospital-Breast Oncology ( Site 2408), Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province ( Site 2430), Taizhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University-Respiratory department ( Site 2409), Wenzhou, Zhejiang
Centro Cancerológico del Caribe (CECAC) ( Site 0509), Barranquilla, Atlantico
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0501), Valledupar, Cesar
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0500), Bogota, Distrito Capital De Bogota
Oncologos del Occidente ( Site 0504), Pereira., Risaralda
Fundación Valle del Lili-Oncology CIC ( Site 0505), Cali, Valle Del Cauca
Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0800), Brno, Brno-mesto
Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 0803), Ostrava-Vitkovice, Ostrava Mesto
Fakultni nemocnice Olomouc-Klinika plicnich nemoci a tuberkulozy ( Site 0802), Olomouc, Not set
Clinique Clairval ( Site 0904), Marseille, Bouches-du-Rhone
Hôpital Robert Schuman ( Site 0907), Vantoux, Lorraine
Institut de Cancérologie de l'Ouest ( Site 0908), ANGERS cedex 02, Maine-et-Loire
Sainte Catherine Institut du Cancer Avignon Provence ( Site 0902), Avignon, Vaucluse
CHD Vendee ( Site 0901), La Roche-sur-Yon, Vendee
Hôpital Saint-Louis ( Site 0906), Paris, Not set
GEFOS Gesellschaft f. onkologische Studien ( Site 1005), Dortmund, Nordrhein-Westfalen
Universitätsklinikum Schleswig-Holstein-Pneumologie ( Site 1000), Luebeck, Schleswig-Holstein
SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1006), Gera, Thuringen
Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1003), Berlin, Not set
Bacs-Kiskun Varmegyei Oktatokorhaz ( Site 1100), Kecskemét, Bacs-Kiskun
Petz Aladar Egyetemi Oktato Korhaz ( Site 1101), Gyor, Gyor-Moson-Sopron
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok
Reformatus Pulmonologiai Centrum ( Site 1102), Torokbalint, Pest
Zala Megyei Szent Rafael Kórház ( Site 1110), Zalaegerszeg, Zala
Országos Korányi Pulmonológiai Intézet ( Site 1104), Budapest, Not set
St. James's Hospital ( Site 1200), Dublin, Not set
Rambam Health Care Campus-Oncology Division ( Site 1302), Haifa, Not set
Shaare Zedek Medical Center ( Site 1300), Jerusalem, Not set
Rabin Medical Center ( Site 1303), Petah Tikva, Not set
Sheba Medical Center ( Site 1301), Ramat Gan, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1401), Napoli, Campania
Azienda Ospedaliera S. Giovanni Addolorata-Oncologia Medica ( Site 1409), Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1404), Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori-Oncologia ( Site 1412), Monza, Lombardia
Istituto Clinico Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1408), Rozzano, Milano
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1402), Rome, Roma
Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1414), Brescia, Not set
Ospedale San Martino ( Site 1407), Genova, Not set
Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 1410), Pavia, Not set
Ospedale di Circolo e Fondazione Macchi Varese-Oncology ( Site 1413), Varese, Not set
Aichi Cancer Center ( Site 2502), Nagoya, Aichi
Nagoya University Hospital ( Site 2519), Nagoya, Aichi
Fujita Health University Hospital ( Site 2515), Toyoake, Aichi
Hirosaki University Hospital ( Site 2514), Hirosaki, Aomori
Ehime University Hospital ( Site 2511), Toon, Ehime
Gunma Prefectural Cancer Center ( Site 2510), Ota, Gunma
Takarazuka City Hospital ( Site 2508), Takarazuka, Hyogo
Kanazawa University Hospital ( Site 2513), Kanazawa, Ishikawa
St. Marianna University Hospital ( Site 2521), Kawasaki, Kanagawa
Kanagawa Cardiovascular and Respiratory Center ( Site 2518), Yokohama, Kanagawa
Kanagawa Cancer Center ( Site 2504), Yokohama, Kanagawa
Matsusaka Municipal Hospital ( Site 2522), Matsusaka, Mie
Sendai Kousei Hospital ( Site 2507), Sendai, Miyagi
Kansai Medical University Hospital ( Site 2503), Hirakata, Osaka
Saitama Prefectural Cancer Center ( Site 2512), Kitaadachi-gun, Saitama
Cancer Institute Hospital of JFCR ( Site 2500), Koto, Tokyo
Toho University Omori Medical Center ( Site 2520), Ota, Tokyo
National Center for Global Health and Medicine ( Site 2516), Shinjuku, Tokyo
National Hospital Organization Yamaguchi Ube Medical Center ( Site 2523), Ube, Yamaguchi
Chiba University Hospital ( Site 2517), Chiba, Not set
National Hospital Organization Kyushu Medical Center ( Site 2509), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 2505), Niigata, Not set
Osaka International Cancer Institute ( Site 2506), Osaka, Not set
The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 2106), Bupyeong-gu, Incheon
Pusan National University Yangsan Hospital ( Site 2104), Yangsan-si, Kyongsangnam-do
Pusan National University Hospital ( Site 2100), Busan, Pusan-Kwangyokshi
Kyungpook National University Chilgok Hospital-Pulmonology ( Site 2102), Deagu, Taegu-Kwangyokshi
Chungnam national university hospital-Department of Internal Medicine ( Site 2107), Daejeon, Taejon-Kwangyokshi
Kyung Hee University Hospital ( Site 2101), Seoul, Not set
Asan Medical Center ( Site 2105), Seoul, Not set
Korea University Guro Hospital-Internal Medicine ( Site 2103), Seoul, Not set
Clínicas AUNA Sede Chiclayo ( Site 0604), Chiclayo, Lambayeque
Oncosalud-Clinical Research ( Site 0600), Lima, Not set
Hospital Militar Central Coronel Luis Arias Schereiber ( Site 0602), Lima, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 1510), Poznań, Dolnoslaskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1503), Bydgoszcz, Kujawsko-pomorskie
Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 1513), Grudziadz, Kujawsko-pomorskie
Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1507), Gorlice, Malopolskie
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1515), Kraków, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1500), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1501), Przemysl, Podkarpackie
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1517), Koszalin, Zachodniopomorskie
Centrul Medical Medicover Victoria ( Site 2000), Bucharest, Bucuresti
Cardiomed SRL Cluj-Napoca ( Site 2002), Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2001), Florești, Cluj
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2004), Craiova, Dolj
Cabinet Medical Oncomed ( Site 2005), Timisoara, Timis
SC ONCO CARD SRL ( Site 2007), Brasov, Not set
Clinica Polisano ( Site 2008), Sibiu, Not set
CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 1703), Santiago de Compostela, Galicia
Hospital Insular de Gran Canaria-Oncology ( Site 1701), Las Palmas de Gran Canaria, Las Palmas
Hospital Quirón Málaga ( Site 1704), Málaga, Malaga
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1700), Barcelona, Not set
Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 1702), Madrid, Not set
Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 1705), Sevilla, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 2209), Taipei City, Taipei
Taoyuan General Hospital ( Site 2203), Taoyuan City, Taoyuan
Chang Gung Memorial Hospital at Kaohsiung ( Site 2207), Kaohsiung, Not set
Taichung Veterans General Hospital ( Site 2204), Taichung, Not set
National Cheng Kung University Hospital ( Site 2205), Tainan, Not set
National Taiwan University Hospital-Oncology ( Site 2208), Taipei, Not set
Mackay Memorial Hospital-Chest Medicine ( Site 2201), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch-Clinic of Chest Medicine ( Site 2202), Taoyuan, Not set
Prapokklao Hospital ( Site 2306), Mueang, Chanthaburi
Faculty of Medicine - Khon Kaen University ( Site 2305), Muang, Khon Kaen
Faculty of Medicine Siriraj Hospital ( Site 2301), Bangkok, Krung Thep Maha Nakhon
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2300), Dusit, Krung Thep Maha Nakhon
Lampang Cancer Hospital ( Site 2304), Mueang Lampang, Lampang
Songklanagarind hospital ( Site 2303), HatYai, Songkhla
Maharaj Nakorn Chiang Mai Hospital ( Site 2302), Chiang Mai, Not set
Medipol Mega Universite Hastanesi-oncology ( Site 1811), Stanbul, Istanbul
Hacettepe Universite Hastaneleri-oncology hospital ( Site 1801), Ankara, Not set
Gazi Universitesi-Oncology ( Site 1804), Ankara, Not set
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1800), Ankara, Not set
Memorial Kayseri Hastanesi ( Site 1805), Kayseri, Not set
Mersin Sehir Eğitim ve Araştırma Hastanesi-Oncology ( Site 1808), Mersin, Not set
Samsun Medical Park Hastanesi-medical oncology ( Site 1806), Samsun, Not set
Burjeel Medical City ( Site 2600), Abu Dhabi, Abu Zaby
Torbay Hospital ( Site 1906), Torquay, Devon
St Bartholomew's Hospital ( Site 1901), London, London, City Of
City Hospital, Nottingham University Hospitals NHS Trust-NCCTT ( Site 1911), Nottingham, Nottinghamshire
Conditions: Non-small Cell Lung Cancer, NSCLC
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Active Not Recruiting
This phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy in treating patients with platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer that has come back. Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may stop the growth of ovarian, fallopian tube, or primary peritoneal cancer by blocking the... Read More
This phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy in treating patients with platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer that has come back. Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may stop the growth of ovarian, fallopian tube, or primary peritoneal cancer by blocking the growth of new blood vessels necessary for tumor growth. Drugs used in chemotherapy, such as carboplatin, paclitaxel, gemcitabine hydrochloride, and pegylated liposomal doxorubicin hydrochloride work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether olaparib or cediranib maleate and olaparib is more effective than standard platinum-based chemotherapy in treating patients with platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +355 locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama
Alaska Women's Cancer Care, Anchorage, Alaska
Providence Alaska Medical Center, Anchorage, Alaska
Arizona Oncology Associates-West Orange Grove, Tucson, Arizona
Arizona Oncology Associates-Wilmot, Tucson, Arizona
University of Arkansas for Medical Sciences, Little Rock, Arkansas
PCR Oncology, Arroyo Grande, California
Mercy San Juan Medical Center, Carmichael, California
Marin Cancer Care Inc, Greenbrae, California
UC San Diego Moores Cancer Center, La Jolla, California
Cedars Sinai Medical Center, Los Angeles, California
Palo Alto Medical Foundation-Camino Division, Mountain View, California
Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California
Kaiser Permanente-Oakland, Oakland, California
Palo Alto Medical Foundation Health Care, Palo Alto, California
Sutter Roseville Medical Center, Roseville, California
Mercy Cancer Center - Sacramento, Sacramento, California
Sutter Medical Center Sacramento, Sacramento, California
University of California Davis Comprehensive Cancer Center, Sacramento, California
Kaiser Permanente Sacramento Medical Center, Sacramento, California
California Pacific Medical Center-Pacific Campus, San Francisco, California
Kaiser Permanente-San Francisco, San Francisco, California
UCSF Medical Center-Mission Bay, San Francisco, California
Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California
Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California
Sutter Pacific Medical Foundation, Santa Rosa, California
Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California
Kaiser Permanente-Vallejo, Vallejo, California
Kaiser Permanente-Walnut Creek, Walnut Creek, California
Woodland Memorial Hospital, Woodland, California
Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado
UCHealth University of Colorado Hospital, Aurora, Colorado
Penrose-Saint Francis Healthcare, Colorado Springs, Colorado
UCHealth Memorial Hospital Central, Colorado Springs, Colorado
Kaiser Permanente-Franklin, Denver, Colorado
Rocky Mountain Cancer Centers-Rose, Denver, Colorado
Poudre Valley Hospital, Fort Collins, Colorado
Kaiser Permanente-Rock Creek, Lafayette, Colorado
Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado
Kaiser Permanente-Lone Tree, Lone Tree, Colorado
Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado
Intermountain Health Lutheran Hospital, Wheat Ridge, Colorado
Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut
Hartford Hospital, Hartford, Connecticut
Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut
Middlesex Hospital, Middletown, Connecticut
The Hospital of Central Connecticut, New Britain, Connecticut
Yale University, New Haven, Connecticut
Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut
Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut
Helen F Graham Cancer Center, Newark, Delaware
Christiana Care Health System-Christiana Hospital, Newark, Delaware
Beebe Health Campus, Rehoboth Beach, Delaware
TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware
Sibley Memorial Hospital, Washington, District of Columbia
University of Florida Health Science Center - Gainesville, Gainesville, Florida
University Cancer and Blood Center LLC, Athens, Georgia
Piedmont Hospital, Atlanta, Georgia
Northside Hospital, Atlanta, Georgia
Emory Decatur Hospital, Decatur, Georgia
Atrium Health Navicent, Macon, Georgia
Memorial Health University Medical Center, Savannah, Georgia
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia
Queen's Medical Center, Honolulu, Hawaii
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho
Saint Luke's Cancer Institute - Meridian, Meridian, Idaho
Saint Luke's Cancer Institute - Nampa, Nampa, Idaho
Rush-Copley Medical Center, Aurora, Illinois
Illinois CancerCare-Bloomington, Bloomington, Illinois
Illinois CancerCare-Canton, Canton, Illinois
Illinois CancerCare-Carthage, Carthage, Illinois
Centralia Oncology Clinic, Centralia, Illinois
Northwestern University, Chicago, Illinois
John H Stroger Jr Hospital of Cook County, Chicago, Illinois
Rush University Medical Center, Chicago, Illinois
UChicago Medicine Comprehensive Cancer Center - Saint Joseph Hospital, Chicago, Illinois
Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois
Decatur Memorial Hospital, Decatur, Illinois
Crossroads Cancer Center, Effingham, Illinois
Illinois CancerCare-Eureka, Eureka, Illinois
NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois
Illinois CancerCare-Galesburg, Galesburg, Illinois
Northwestern Medicine Cancer Center Delnor, Geneva, Illinois
NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois
NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois
Sudarshan K Sharma MD Limited-Gynecologic Oncology, Hinsdale, Illinois
Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois
Illinois CancerCare-Macomb, Macomb, Illinois
Cancer Care Center of O'Fallon, O'Fallon, Illinois
Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois
Advocate Lutheran General Hospital, Park Ridge, Illinois
Illinois CancerCare-Pekin, Pekin, Illinois
Illinois CancerCare-Peoria, Peoria, Illinois
Illinois CancerCare-Peru, Peru, Illinois
Illinois CancerCare-Princeton, Princeton, Illinois
Springfield Clinic, Springfield, Illinois
Springfield Memorial Hospital, Springfield, Illinois
Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois
Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana
Mercy Cancer Center-West Lakes, Clive, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa
Iowa Methodist Medical Center, Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa
Mercy Medical Center - Des Moines, Des Moines, Iowa
UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
Mercy Medical Center-West Lakes, West Des Moines, Iowa
University of Kansas Cancer Center, Kansas City, Kansas
Mercy Hospital Pittsburg, Pittsburg, Kansas
Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka, Kansas
Associates In Womens Health, Wichita, Kansas
Ascension Via Christi Hospitals Wichita, Wichita, Kansas
University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Norton Hospital Pavilion and Medical Campus, Louisville, Kentucky
Norton Suburban Hospital and Medical Campus, Louisville, Kentucky
Norton Brownsboro Hospital and Medical Campus, Louisville, Kentucky
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
Woman's Hospital, Baton Rouge, Louisiana
Women's Cancer Care-Covington, Covington, Louisiana
Ochsner Medical Center Jefferson, New Orleans, Louisiana
Eastern Maine Medical Center, Bangor, Maine
Lafayette Family Cancer Center-EMMC, Brewer, Maine
MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine
Greater Baltimore Medical Center, Baltimore, Maryland
MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, Maryland
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
University of Maryland Shore Medical Center at Easton, Easton, Maryland
Tufts Medical Center, Boston, Massachusetts
Brigham and Women's Hospital, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Lahey Hospital and Medical Center, Burlington, Massachusetts
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Henry Ford Cancer Institute-Downriver, Brownstown, Michigan
Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Henry Ford Hospital, Detroit, Michigan
OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan
Weisberg Cancer Treatment Center, Farmington Hills, Michigan
Genesys Hurley Cancer Institute, Flint, Michigan
Hurley Medical Center, Flint, Michigan
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan
West Michigan Cancer Center, Kalamazoo, Michigan
University of Michigan Health - Sparrow Lansing, Lansing, Michigan
Green Bay Oncology-Manistique, Manistique, Michigan
Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan
Henry Ford Health Providence Southfield Hospital, Southfield, Michigan
Munson Medical Center, Traverse City, Michigan
Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan
Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
Fairview Ridges Hospital, Burnsville, Minnesota
Mercy Hospital, Coon Rapids, Minnesota
Fairview Southdale Hospital, Edina, Minnesota
Mayo Clinic Health Systems-Mankato, Mankato, Minnesota
Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota
Saint John's Hospital - Healtheast, Maplewood, Minnesota
Abbott-Northwestern Hospital, Minneapolis, Minnesota
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota
Regions Hospital, Saint Paul, Minnesota
United Hospital, Saint Paul, Minnesota
Saint Francis Regional Medical Center, Shakopee, Minnesota
Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota
Saint Dominic-Jackson Memorial Hospital, Jackson, Mississippi
University of Mississippi Medical Center, Jackson, Mississippi
Saint Francis Medical Center, Cape Girardeau, Missouri
Mercy Hospital Joplin, Joplin, Missouri
Barnes-Jewish Hospital, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital Springfield, Springfield, Missouri
CoxHealth South Hospital, Springfield, Missouri
Billings Clinic Cancer Center, Billings, Montana
Benefis Sletten Cancer Institute, Great Falls, Montana
Logan Health Medical Center, Kalispell, Montana
Community Medical Center, Missoula, Montana
Nebraska Cancer Specialists/Oncology Hematology West PC, Grand Island, Nebraska
CHI Health Good Samaritan, Kearney, Nebraska
Nebraska Methodist Hospital, Omaha, Nebraska
Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska
Alegent Health Lakeside Hospital, Omaha, Nebraska
Women's Cancer Center of Nevada, Las Vegas, Nevada
Wentworth-Douglass Hospital, Dover, New Hampshire
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Dartmouth Cancer Center - Nashua, Nashua, New Hampshire
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Cooper Hospital University Medical Center, Camden, New Jersey
Englewood Hospital and Medical Center, Englewood, New Jersey
MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey
Southwest Gynecologic Oncology Associates Inc, Albuquerque, New Mexico
University of New Mexico Cancer Center, Albuquerque, New Mexico
Memorial Medical Center-Las Cruces, Las Cruces, New Mexico
Montefiore Medical Center-Einstein Campus, Bronx, New York
State University of New York Downstate Medical Center, Brooklyn, New York
Roswell Park Cancer Institute, Buffalo, New York
Memorial Sloan Kettering Commack, Commack, New York
Memorial Sloan Kettering Westchester, Harrison, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
University of Rochester, Rochester, New York
Memorial Sloan Kettering Nassau, Uniondale, New York
Dickstein Cancer Treatment Center, White Plains, New York
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Duke University Medical Center, Durham, North Carolina
Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina
Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina
FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina
Duke Cancer Center Raleigh, Raleigh, North Carolina
Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina
Wake Forest University Health Sciences, Winston-Salem, North Carolina
Sanford Bismarck Medical Center, Bismarck, North Dakota
Sanford Broadway Medical Center, Fargo, North Dakota
Sanford Roger Maris Cancer Center, Fargo, North Dakota
Trinity Cancer Care Center, Minot, North Dakota
Summa Health System - Akron Campus, Akron, Ohio
Cleveland Clinic Akron General, Akron, Ohio
UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio
TriHealth Cancer Institute-Westside, Cincinnati, Ohio
Case Western Reserve University, Cleveland, Ohio
MetroHealth Medical Center, Cleveland, Ohio
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Columbus Oncology and Hematology Associates Inc, Columbus, Ohio
Riverside Methodist Hospital, Columbus, Ohio
The Mark H Zangmeister Center, Columbus, Ohio
Grandview Hospital, Dayton, Ohio
Orion Cancer Care, Findlay, Ohio
Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio
UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio
ProMedica Flower Hospital, Sylvania, Ohio
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio
University Hospitals Sharon Health Center, Wadsworth, Ohio
UHHS-Westlake Medical Center, Westlake, Ohio
Wright-Patterson Medical Center, Wright-Patterson Air Force Base, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma
Saint Charles Health System, Bend, Oregon
Willamette Valley Cancer Center, Eugene, Oregon
Legacy Mount Hood Medical Center, Gresham, Oregon
Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon
Kaiser Permanente Northwest, Portland, Oregon
Legacy Meridian Park Hospital, Tualatin, Oregon
Jefferson Abington Hospital, Abington, Pennsylvania
Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania
Geisinger Medical Center, Danville, Pennsylvania
Ephrata Cancer Center, Ephrata, Pennsylvania
Adams Cancer Center, Gettysburg, Pennsylvania
Lancaster General Hospital, Lancaster, Pennsylvania
University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
West Penn Hospital, Pittsburgh, Pennsylvania
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania
Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania
Reading Hospital, West Reading, Pennsylvania
UPMC Susquehanna, Williamsport, Pennsylvania
WellSpan Health-York Hospital, York, Pennsylvania
Women and Infants Hospital, Providence, Rhode Island
AnMed Health Cancer Center, Anderson, South Carolina
Medical University of South Carolina, Charleston, South Carolina
Gibbs Cancer Center-Gaffney, Gaffney, South Carolina
Saint Francis Hospital, Greenville, South Carolina
Prisma Health Cancer Institute - Faris, Greenville, South Carolina
Saint Francis Cancer Center, Greenville, South Carolina
Gibbs Cancer Center-Pelham, Greer, South Carolina
South Carolina Cancer Specialists PC, Hilton Head Island, South Carolina
Spartanburg Medical Center, Spartanburg, South Carolina
SMC Center for Hematology Oncology Union, Union, South Carolina
Rapid City Regional Hospital, Rapid City, South Dakota
Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
Avera Cancer Institute, Sioux Falls, South Dakota
Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
Wellmont Medical Associates Oncology and Hematology-Johnson City, Johnson City, Tennessee
Ballad Health Cancer Care - Kingsport, Kingsport, Tennessee
Wellmont Holston Valley Hospital and Medical Center, Kingsport, Tennessee
Thompson Cancer Survival Center, Knoxville, Tennessee
Thompson Cancer Survival Center - West, Knoxville, Tennessee
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Texas Oncology - Central Austin Cancer Center, Austin, Texas
Texas Oncology - South Austin Cancer Center, Austin, Texas
Texas Oncology Bedford, Bedford, Texas
Parkland Memorial Hospital, Dallas, Texas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas
Houston Methodist Hospital, Houston, Texas
Methodist Willowbrook Hospital, Houston, Texas
Houston Methodist Sugar Land Hospital, Sugar Land, Texas
Texas Oncology-The Woodlands, The Woodlands, Texas
Intermountain Medical Center, Murray, Utah
Saint George Regional Medical Center, Saint George, Utah
Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah
University of Virginia Cancer Center, Charlottesville, Virginia
VCU Massey Comprehensive Cancer Center, Richmond, Virginia
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
Skagit Regional Health Cancer Care Center, Mount Vernon, Washington
Skagit Valley Hospital, Mount Vernon, Washington
Pacific Gynecology Specialists, Seattle, Washington
Fred Hutchinson Cancer Center, Seattle, Washington
Swedish Medical Center-First Hill, Seattle, Washington
University of Washington Medical Center - Northwest, Seattle, Washington
Women's Cancer Center of Seattle, Seattle, Washington
University of Washington Medical Center - Montlake, Seattle, Washington
Legacy Salmon Creek Hospital, Vancouver, Washington
Wenatchee Valley Hospital and Clinics, Wenatchee, Washington
West Virginia University Charleston Division, Charleston, West Virginia
Edwards Comprehensive Cancer Center, Huntington, West Virginia
Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin
Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin
Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin
Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin
Gundersen Lutheran Medical Center, La Crosse, Wisconsin
Marshfield Medical Center - Ladysmith, Ladysmith, Wisconsin
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Saint Vincent Hospital Cancer Center at Marinette, Marinette, Wisconsin
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
Medical College of Wisconsin, Milwaukee, Wisconsin
Marshfield Medical Center - Minocqua, Minocqua, Wisconsin
ProHealth D N Greenwald Center, Mukwonago, Wisconsin
ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin
Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin
Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin
Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin
Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin
Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin
ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin
UW Cancer Center at ProHealth Care, Waukesha, Wisconsin
Marshfield Clinic-Wausau Center, Wausau, Wisconsin
Marshfield Medical Center - Weston, Weston, Wisconsin
Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta
Cross Cancer Institute, Edmonton, Alberta
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario
London Regional Cancer Program, London, Ontario
Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario
Algoma District Cancer Program Sault Area Hospital, Sault Ste Marie, Ontario
Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario
University Health Network-Princess Margaret Hospital, Toronto, Ontario
CIUSSSEMTL-Hopital Maisonneuve-Rosemont, Montreal, Quebec
CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec
Jewish General Hospital, Montreal, Quebec
CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec
Iwate Medical University Hospital, Shiwa-gun, Iwate
Kagoshima City Hospital, Kagoshima City, Kagoshima
The Cancer Institute Hospital Of JFCR, Koto-ku, Tokyo
Saitama Medical University International Medical Center, Saitama, Not set
National Cancer Center Hospital, Tokyo, Not set
Seoul National University Hospital, Seoul, Not set
Conditions: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Tumor, Ovarian Seromucinous Carcinoma, Ovarian Serous Tumor, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal Carcinoma
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
Active Not Recruiting
This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back after a period of improvement (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Paclitaxel and carboplatin are... Read More
This phase III trial studies how well the combination of pembrolizumab, paclitaxel and carboplatin works compared with paclitaxel and carboplatin alone in treating patients with endometrial cancer that is stage III or IV, or has come back after a period of improvement (recurrent). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Paclitaxel and carboplatin are chemotherapy drugs used as part of the usual treatment approach for this type of cancer. This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
07/25/2025
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +396 locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Alaska Women's Cancer Care, Anchorage, Alaska
CTCA at Western Regional Medical Center, Goodyear, Arizona
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas
University of Arkansas for Medical Sciences, Little Rock, Arkansas
Kaiser Permanente-Baldwin Park, Baldwin Park, California
Kaiser Permanente-Bellflower, Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California
Community Cancer Institute, Clovis, California
City of Hope Comprehensive Cancer Center, Duarte, California
Kaiser Permanente South Bay, Harbor City, California
Kaiser Permanente-Irvine, Irvine, California
UC San Diego Moores Cancer Center, La Jolla, California
City of Hope Antelope Valley, Lancaster, California
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
Los Angeles General Medical Center, Los Angeles, California
USC / Norris Comprehensive Cancer Center, Los Angeles, California
Cedars Sinai Medical Center, Los Angeles, California
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California
Kaiser Permanente-Oakland, Oakland, California
Saint Joseph Hospital - Orange, Orange, California
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
Eisenhower Medical Center, Rancho Mirage, California
Mercy Regional Cancer Center, Redding, California
Mercy Oncology Center, Redding, California
Kaiser Permanente-Riverside, Riverside, California
Kaiser Permanente-Roseville, Roseville, California
Kaiser Permanente Downtown Commons, Sacramento, California
Mercy Cancer Center - Sacramento, Sacramento, California
University of California Davis Comprehensive Cancer Center, Sacramento, California
Kaiser Permanente-San Diego Zion, San Diego, California
Naval Medical Center -San Diego, San Diego, California
Zuckerberg San Francisco General Hospital, San Francisco, California
California Pacific Medical Center-Pacific Campus, San Francisco, California
Kaiser Permanente-San Francisco, San Francisco, California
UCSF Medical Center-Mission Bay, San Francisco, California
Kaiser Permanente-Santa Teresa-San Jose, San Jose, California
Kaiser Permanente San Leandro, San Leandro, California
Kaiser Permanente-San Marcos, San Marcos, California
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California
City of Hope South Pasadena, South Pasadena, California
Kaiser Permanente-South San Francisco, South San Francisco, California
Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California
City of Hope Upland, Upland, California
Kaiser Permanente-Vallejo, Vallejo, California
Kaiser Permanente-Walnut Creek, Walnut Creek, California
John Muir Medical Center-Walnut Creek, Walnut Creek, California
Penrose-Saint Francis Healthcare, Colorado Springs, Colorado
UCHealth Memorial Hospital Central, Colorado Springs, Colorado
Memorial Hospital North, Colorado Springs, Colorado
Poudre Valley Hospital, Fort Collins, Colorado
Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado
Banner North Colorado Medical Center, Greeley, Colorado
UCHealth Greeley Hospital, Greeley, Colorado
Medical Center of the Rockies, Loveland, Colorado
Banner McKee Medical Center, Loveland, Colorado
Danbury Hospital, Danbury, Connecticut
Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut
Hartford Hospital, Hartford, Connecticut
Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut
The Hospital of Central Connecticut, New Britain, Connecticut
Yale University, New Haven, Connecticut
Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut
Norwalk Hospital, Norwalk, Connecticut
Stamford Hospital/Bennett Cancer Center, Stamford, Connecticut
Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut
Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut
Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut
Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut
Helen F Graham Cancer Center, Newark, Delaware
MedStar Washington Hospital Center, Washington, District of Columbia
Sibley Memorial Hospital, Washington, District of Columbia
Florida Cancer Specialists - Bradenton Cancer Center, Bradenton, Florida
Florida Cancer Specialists - Sarasota, Sarasota, Florida
Florida Cancer Specialists - Sarasota Downtown, Sarasota, Florida
Sarasota Memorial Hospital, Sarasota, Florida
Florida Cancer Specialists - Venice Pinebrook, Venice, Florida
Florida Cancer Specialists - Venice Island, Venice, Florida
Grady Health System, Atlanta, Georgia
Emory University Hospital Midtown, Atlanta, Georgia
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Emory Saint Joseph's Hospital, Atlanta, Georgia
Northside Hospital, Atlanta, Georgia
WellStar Cobb Hospital, Austell, Georgia
Piedmont Fayette Hospital, Fayetteville, Georgia
Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia
WellStar Health System Inc, Marietta, Georgia
Wellstar Kennestone Hospital, Marietta, Georgia
CTCA at Southeastern Regional Medical Center, Newnan, Georgia
WellStar North Fulton Hospital, Roswell, Georgia
Memorial Health University Medical Center, Savannah, Georgia
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia
WellStar Vinings Health Park, Smyrna, Georgia
Queen's Medical Center, Honolulu, Hawaii
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho
Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho
Saint Luke's Cancer Institute - Meridian, Meridian, Idaho
Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho
Saint Luke's Cancer Institute - Nampa, Nampa, Idaho
Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho
Northwestern University, Chicago, Illinois
Rush University Medical Center, Chicago, Illinois
University of Illinois, Chicago, Illinois
University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Carle at The Riverfront, Danville, Illinois
Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois
Crossroads Cancer Center, Effingham, Illinois
NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois
Northwestern Medicine Cancer Center Delnor, Geneva, Illinois
NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois
Ingalls Memorial Hospital, Harvey, Illinois
NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois
Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
Loyola University Medical Center, Maywood, Illinois
UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois
Cancer Care Center of O'Fallon, O'Fallon, Illinois
University of Chicago Medicine-Orland Park, Orland Park, Illinois
Springfield Clinic, Springfield, Illinois
Carle Cancer Center, Urbana, Illinois
Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois
Midwestern Regional Medical Center, Zion, Illinois
Northwest Cancer Center - Main Campus, Crown Point, Indiana
Northwest Oncology LLC, Dyer, Indiana
Northwest Cancer Center - Hobart, Hobart, Indiana
Saint Mary Medical Center, Hobart, Indiana
Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Community Cancer Center East, Indianapolis, Indiana
Community Cancer Center South, Indianapolis, Indiana
Franciscan Health Indianapolis, Indianapolis, Indiana
Community Cancer Center North, Indianapolis, Indiana
Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana
Saint Catherine Hospital, Indianapolis, Indiana
Franciscan Health Mooresville, Mooresville, Indiana
The Community Hospital, Munster, Indiana
Women's Diagnostic Center - Munster, Munster, Indiana
Northwest Cancer Center - Valparaiso, Valparaiso, Indiana
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
University of Kansas Clinical Research Center, Fairway, Kansas
University of Kansas Cancer Center, Kansas City, Kansas
University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
Saint Elizabeth Healthcare Edgewood, Edgewood, Kentucky
LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana
Our Lady of the Lake Physician Group, Baton Rouge, Louisiana
Our Lady of The Lake, Baton Rouge, Louisiana
Our Lady of the Lake Medical Oncology, Baton Rouge, Louisiana
Woman's Hospital, Baton Rouge, Louisiana
East Jefferson General Hospital, Metairie, Louisiana
University Medical Center New Orleans, New Orleans, Louisiana
Ochsner Baptist Medical Center, New Orleans, Louisiana
Ochsner Medical Center Jefferson, New Orleans, Louisiana
Harold Alfond Center for Cancer Care, Augusta, Maine
MaineHealth Waldo Hospital, Belfast, Maine
MaineHealth Maine Medical Center - Biddeford, Biddeford, Maine
Lafayette Family Cancer Center-EMMC, Brewer, Maine
Penobscot Bay Medical Center, Rockport, Maine
MaineHealth Cancer Care and IV Therapy - Sanford, Sanford, Maine
MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine
Luminis Health Anne Arundel Medical Center, Annapolis, Maryland
University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Greater Baltimore Medical Center, Baltimore, Maryland
Sinai Hospital of Baltimore, Baltimore, Maryland
Saint Agnes Hospital, Baltimore, Maryland
MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, Maryland
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
UM Upper Chesapeake Medical Center, Bel Air, Maryland
Walter Reed National Military Medical Center, Bethesda, Maryland
University of Maryland Shore Medical Center at Easton, Easton, Maryland
Lahey Hospital and Medical Center, Burlington, Massachusetts
Lowell General Hospital, Lowell, Massachusetts
Baystate Medical Center, Springfield, Massachusetts
Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care, Winchester, Massachusetts
UMass Memorial Medical Center - Memorial Division, Worcester, Massachusetts
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Cancer Hematology Centers - Flint, Flint, Michigan
Genesee Hematology Oncology PC, Flint, Michigan
Genesys Hurley Cancer Institute, Flint, Michigan
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan
Bronson Methodist Hospital, Kalamazoo, Michigan
West Michigan Cancer Center, Kalamazoo, Michigan
University of Michigan Health - Sparrow Lansing, Lansing, Michigan
Munson Medical Center, Traverse City, Michigan
Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
Essentia Health Cancer Center, Duluth, Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota
Mississippi Baptist Medical Center, Jackson, Mississippi
University of Mississippi Medical Center, Jackson, Mississippi
Saint Luke's Hospital of Kansas City, Kansas City, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital Saint Louis, Saint Louis, Missouri
Mercy Hospital Springfield, Springfield, Missouri
Community Hospital of Anaconda, Anaconda, Montana
Billings Clinic Cancer Center, Billings, Montana
Nebraska Cancer Specialists/Oncology Hematology West PC, Grand Island, Nebraska
Nebraska Methodist Hospital, Omaha, Nebraska
University of Nebraska Medical Center, Omaha, Nebraska
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Cooper Hospital University Medical Center, Camden, New Jersey
Monmouth Medical Center Southern Campus, Lakewood, New Jersey
Saint Barnabas Medical Center, Livingston, New Jersey
Monmouth Medical Center, Long Branch, New Jersey
Memorial Sloan Kettering Monmouth, Middletown, New Jersey
Memorial Sloan Kettering Bergen, Montvale, New Jersey
Jersey Shore Medical Center, Neptune, New Jersey
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
The Valley Hospital - Luckow Pavilion, Paramus, New Jersey
Neurosurgeons of New Jersey-Ridgewood, Ridgewood, New Jersey
Valley Health System Ridgewood Campus, Ridgewood, New Jersey
Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey
Community Medical Center, Toms River, New Jersey
MD Anderson Cancer Center at Cooper-Voorhees, Voorhees, New Jersey
Valley Medical Group - Wayne Multispecialty Practice, Wayne, New Jersey
Valley Health System-Hematology/Oncology, Westwood, New Jersey
Southwest Gynecologic Oncology Associates Inc, Albuquerque, New Mexico
University of New Mexico Cancer Center, Albuquerque, New Mexico
Northwell Health Imbert Cancer Center, Bay Shore, New York
Island Gynecologic Oncology, Brightwaters, New York
Montefiore Medical Center-Einstein Campus, Bronx, New York
Montefiore Medical Center - Moses Campus, Bronx, New York
New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York
Roswell Park Cancer Institute, Buffalo, New York
Memorial Sloan Kettering Commack, Commack, New York
The New York Hospital Medical Center of Queens, Flushing, New York
Memorial Sloan Kettering Westchester, Harrison, New York
Northwell Health/Center for Advanced Medicine, Lake Success, New York
NYU Langone Hospital - Long Island, Mineola, New York
Long Island Jewish Medical Center, New Hyde Park, New York
Mount Sinai Chelsea, New York, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Mount Sinai Hospital, New York, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
NYP/Weill Cornell Medical Center, New York, New York
Highland Hospital, Rochester, New York
University of Rochester, Rochester, New York
Staten Island University Hospital, Staten Island, New York
Stony Brook University Medical Center, Stony Brook, New York
State University of New York Upstate Medical University, Syracuse, New York
Memorial Sloan Kettering Nassau, Uniondale, New York
Westchester Medical Center, Valhalla, New York
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina
Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina
Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina
Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina
Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina
Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina
Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina
Wake Forest University Health Sciences, Winston-Salem, North Carolina
Sanford Bismarck Medical Center, Bismarck, North Dakota
Sanford Broadway Medical Center, Fargo, North Dakota
Sanford Roger Maris Cancer Center, Fargo, North Dakota
Summa Health System - Akron Campus, Akron, Ohio
UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio
Aultman Health Foundation, Canton, Ohio
Miami Valley Hospital South, Centerville, Ohio
Geauga Hospital, Chardon, Ohio
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio
Case Western Reserve University, Cleveland, Ohio
MetroHealth Medical Center, Cleveland, Ohio
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Riverside Methodist Hospital, Columbus, Ohio
The Mark H Zangmeister Center, Columbus, Ohio
Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio
UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio
ProMedica Flower Hospital, Sylvania, Ohio
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio
UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma
Saint Charles Health System, Bend, Oregon
Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon
Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon
Providence Portland Medical Center, Portland, Oregon
Providence Saint Vincent Medical Center, Portland, Oregon
Legacy Meridian Park Hospital, Tualatin, Oregon
Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania
Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania
Geisinger Medical Center, Danville, Pennsylvania
Ephrata Cancer Center, Ephrata, Pennsylvania
Adams Cancer Center, Gettysburg, Pennsylvania
WellSpan Medical Oncology and Hematology, Hanover, Pennsylvania
Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania
Jefferson Hospital, Jefferson Hills, Pennsylvania
UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania
Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania
Lancaster General Hospital, Lancaster, Pennsylvania
Sechler Family Cancer Center, Lebanon, Pennsylvania
Forbes Hospital, Monroeville, Pennsylvania
UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania
West Penn Hospital, Pittsburgh, Pennsylvania
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania
Community Medical Center, Scranton, Pennsylvania
Reading Hospital, West Reading, Pennsylvania
Wexford Health and Wellness Pavilion, Wexford, Pennsylvania
Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania
Asplundh Cancer Pavilion, Willow Grove, Pennsylvania
WellSpan Health-York Cancer Center, York, Pennsylvania
WellSpan Health-York Hospital, York, Pennsylvania
Women and Infants Hospital, Providence, Rhode Island
Medical University of South Carolina, Charleston, South Carolina
Saint Francis Hospital, Greenville, South Carolina
Prisma Health Cancer Institute - Faris, Greenville, South Carolina
Saint Francis Cancer Center, Greenville, South Carolina
Prisma Health Cancer Institute - Seneca, Seneca, South Carolina
Rapid City Regional Hospital, Rapid City, South Dakota
Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
Avera Cancer Institute, Sioux Falls, South Dakota
Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Parkland Memorial Hospital, Dallas, Texas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
Ben Taub General Hospital, Houston, Texas
Houston Methodist Hospital, Houston, Texas
Methodist Willowbrook Hospital, Houston, Texas
Houston Methodist Sugar Land Hospital, Sugar Land, Texas
Houston Methodist The Woodlands Hospital, The Woodlands, Texas
University of Utah Sugarhouse Health Center, Salt Lake City, Utah
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
University of Vermont Medical Center, Burlington, Vermont
University of Virginia Cancer Center, Charlottesville, Virginia
VCU Massey Comprehensive Cancer Center, Richmond, Virginia
MultiCare Gig Harbor Medical Park, Gig Harbor, Washington
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
MultiCare Good Samaritan Hospital, Puyallup, Washington
Valley Medical Center, Renton, Washington
Swedish Medical Center-First Hill, Seattle, Washington
MultiCare Tacoma General Hospital, Tacoma, Washington
Legacy Salmon Creek Hospital, Vancouver, Washington
West Virginia University Charleston Division, Charleston, West Virginia
Monongalia Hospital, Morgantown, West Virginia
West Virginia University Healthcare, Morgantown, West Virginia
Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin
Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin
Aurora Health Care Germantown Health Center, Germantown, Wisconsin
Aurora Cancer Care-Grafton, Grafton, Wisconsin
Aurora BayCare Medical Center, Green Bay, Wisconsin
Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin
Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin
Aurora Sinai Medical Center, Milwaukee, Wisconsin
Marshfield Medical Center - Minocqua, Minocqua, Wisconsin
ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin
Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin
Aurora Cancer Care-Racine, Racine, Wisconsin
Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin
Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin
Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin
Aurora Medical Center in Summit, Summit, Wisconsin
Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin
UW Cancer Center at ProHealth Care, Waukesha, Wisconsin
Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin
Aurora West Allis Medical Center, West Allis, Wisconsin
Marshfield Medical Center - Weston, Weston, Wisconsin
The Moncton Hospital, Moncton, New Brunswick
Royal Victoria Regional Health Centre, Barrie, Ontario
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario
Kingston Health Sciences Centre, Kingston, Ontario
London Regional Cancer Program, London, Ontario
Lakeridge Health Oshawa, Oshawa, Ontario
Algoma District Cancer Program Sault Area Hospital, Sault Ste Marie, Ontario
Health Sciences North, Sudbury, Ontario
Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Hopital de la Cite-de-la-Sante, Laval, Quebec
CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec
Allan Blair Cancer Centre, Regina, Saskatchewan
Saskatoon Cancer Centre, Saskatoon, Saskatchewan
Ehime University Hospital, Toon, Ehime
Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima
Niigata University Medical and Dental Hospital, Niigata City, Niigata
Saitama Medical University International Medical Center, Saitama, Not set
Keimyung University-Dongsan Medical Center, Dalseo-gu, Daegu
Samsung Changwon Hospital, Seoul, Gyeongsangnam-do
Seoul National University Bundang Hospital, Seongnam City, Kyeonggi-do
Kyungpook National University Chilgok Hospital, Daegu, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Yonsei University Health System-Severance Hospital, Seoul, Not set
Korea Cancer Center Hospital, Seoul, Not set
Centro Comprensivo de Cancer de UPR, San Juan, Not set
Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Dedifferentiated Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Mixed Cell Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma, Recurrent Endometrial Undifferentiated Carcinoma, Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8, Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
Active Not Recruiting
Researchers are looking for new ways to treat people with head and neck cancer whose cancer has come back after treatment (recurrent) or whose cancer has spread to other parts of the body (metastatic). Some people with recurrent or metastatic head and neck cancer are treated with chemotherapy and immunotherapy, but the cancer gets worse.
The goal of this study is to learn if more people who receive lenvatinib and pembrolizumab have a better overall survival rate than people who receive standard... Read More
Researchers are looking for new ways to treat people with head and neck cancer whose cancer has come back after treatment (recurrent) or whose cancer has spread to other parts of the body (metastatic). Some people with recurrent or metastatic head and neck cancer are treated with chemotherapy and immunotherapy, but the cancer gets worse.
The goal of this study is to learn if more people who receive lenvatinib and pembrolizumab have a better overall survival rate than people who receive standard chemotherapy treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: City of Hope ( Site 1519), Duarte, California +119 locations
City of Hope ( Site 1519), Duarte, California
UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1568), Los Angeles, California
Yale-New Haven Hospital-Yale Cancer Center ( Site 1505), New Haven, Connecticut
Georgetown University Medical Center ( Site 1520), Washington, District of Columbia
UF Health ( Site 1554), Gainesville, Florida
Mid Florida Hematology and Oncology Center ( Site 1606), Orange City, Florida
Cleveland Clinic Florida ( Site 1596), Weston, Florida
Georgia Cancer Center at Augusta University ( Site 1575), Augusta, Georgia
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 1521), Marietta, Georgia
Memorial Health University Medical Center ( Site 1626), Savannah, Georgia
Beacon Cancer Care ( Site 1599), Post Falls, Idaho
Rush University Medical Center ( Site 1560), Chicago, Illinois
NorthShore University HealthSystem - Evanston Hospital ( Site 1614), Evanston, Illinois
IU Health Ball Memorial Hospital, Inc.-IU Health Ball Memorial Cancer Center ( Site 1612), Muncie, Indiana
University of Iowa ( Site 1572), Iowa City, Iowa
University of Kansas Cancer Center ( Site 1538), Westwood, Kansas
Norton Hospital-Norton Cancer Institute - Downtown ( Site 1601), Louisville, Kentucky
Mercy Health-Paducah Cancer Center ( Site 1623), Paducah, Kentucky
Our Lady of the Lake RMC-Clinical Research ( Site 1624), Baton Rouge, Louisiana
Mary Bird Perkins Cancer Center Baton Rouge ( Site 1622), Baton Rouge, Louisiana
University of Maryland Greenebaum Cancer Center ( Site 1522), Baltimore, Maryland
Boston Medical Center ( Site 1605), Boston, Massachusetts
University of Massachusetts Chan Medical School ( Site 1616), Worcester, Massachusetts
VA Ann Arbor Healthcare System ( Site 1584), Ann Arbor, Michigan
Barbara Ann Karmanos Cancer Institute ( Site 1566), Detroit, Michigan
Henry Ford Health System ( Site 1544), Detroit, Michigan
Hattiesburg Clinic ( Site 1515), Hattiesburg, Mississippi
Jackson Oncology Associates, PLLC-Clinical Trials ( Site 1625), Jackson, Mississippi
Washington University School of Medicine ( Site 1500), Saint Louis, Missouri
St. Vincent Frontier Cancer Center ( Site 1507), Billings, Montana
University Of Nebraska Medical Center ( Site 1570), Omaha, Nebraska
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 1627), Omaha, Nebraska
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1555), Hackensack, New Jersey
Rutgers Cancer Institute of New Jersey ( Site 1523), New Brunswick, New Jersey
Perlmutter Cancer Center at Winthrop Oncology Hematology Associates NYU Langone Health ( Site 1597), Mineola, New York
Laura and Isaac Perlmutter Cancer Center ( Site 1582), New York, New York
Levine Cancer Institute ( Site 1590), Charlotte, North Carolina
Duke Cancer Institute ( Site 1541), Durham, North Carolina
University of Cincinnati Medical Center ( Site 1567), Cincinnati, Ohio
University Hospital Cleveland ( Site 1578), Cleveland, Ohio
Cleveland Clinic Main ( Site 1598), Cleveland, Ohio
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 1558), Columbus, Ohio
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 1508), Tulsa, Oklahoma
Gettysburg Cancer Center ( Site 1594), Gettysburg, Pennsylvania
Penn State Hershey Medical Center ( Site 1561), Hershey, Pennsylvania
Fox Chase Cancer Center ( Site 1502), Philadelphia, Pennsylvania
Medical University of South Carolina ( Site 1579), Charleston, South Carolina
St Francis Cancer Center-Research Office ( Site 1607), Greenville, South Carolina
The Center For Cancer And Blood Disorders ( Site 1569), Fort Worth, Texas
Utah Cancer Specialists ( Site 1621), Salt Lake City, Utah
Huntsman Cancer Institute ( Site 1532), Salt Lake City, Utah
Inova Schar Cancer Institute ( Site 1550), Fairfax, Virginia
Hematology Oncology Associates of Fredericksburg ( Site 1537), Fredericksburg, Virginia
MultiCare Health System-MultiCare Oncology - Puget Sound ( Site 1609), Tacoma, Washington
Medical College of Wisconsin Clinical Cancer Center ( Site 1574), Milwaukee, Wisconsin
Mid North Coast Cancer Institute ( Site 0109), Port Macquarie, New South Wales
Blacktown Hospital ( Site 0101), Sydney, New South Wales
The Townsville Hospital ( Site 0107), Douglas, Queensland
Gallipoli Medical Research Ltd-GMRF CTU ( Site 0105), Greenslopes, Queensland
Royal Adelaide Hospital ( Site 0110), Adelaide, South Australia
Monash Health ( Site 0102), Clayton, Victoria
Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 0806), Porto Alegre, Rio Grande Do Sul
A. C. Camargo Cancer Center ( Site 0809), Sao Paulo, Not set
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0304), Calgary, Alberta
BC Cancer-Vancouver Center ( Site 0306), Vancouver, British Columbia
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0307), Hamilton, Ontario
Sunnybrook Research Institute ( Site 0308), Toronto, Ontario
Instituto de Cancerología ( Site 0408), Medellin., Antioquia
Sociedad De Oncologia Y Hematologia Del Cesar ( Site 0404), Valledupar, Cesar
IMAT S.A.S ( Site 0409), Montería, Cordoba
Administradora Country S.A.S - Clínica del Country ( Site 0407), Bogotá, Cundinamarca
Rigshospitalet University Hospital Copenhagen ( Site 1000), Copenhagen, Hovedstaden
Hopital La Timone ( Site 0503), Marseille, Bouches-du-Rhone
Centre de Cancerologie du Grand Montpellier ( Site 0508), Montpellier, Herault
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 0510), Clermont-Ferrand, Puy-de-Dome
Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen ( Site 0509), Rouen, Seine-Maritime
Institut Gustave Roussy ( Site 0505), Villejuif, Val-de-Marne
Institut Curie ( Site 0500), Paris, Not set
Soroka Medical Center-Oncology ( Site 0604), Be'er Sheva, Not set
Rambam Health Care Campus-Oncology Division ( Site 0602), Haifa, Not set
Hadassah Medical Center. Ein Kerem ( Site 0601), Jerusalem, Not set
Chaim Sheba Medical Center ( Site 0600), Ramat Gan, Not set
Seoul National University Bundang Hospital ( Site 1801), Seongnam, Kyonggi-do
Ajou University Hospital ( Site 1802), Suwon, Kyonggi-do
Severance Hospital Yonsei University Health System ( Site 1800), Seoul, Not set
Samsung Medical Center ( Site 1803), Seoul, Not set
Oslo universitetssykehus, Radiumhospitalet ( Site 1102), Oslo, Not set
Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 1401), Vila Nova de Gaia, Porto
Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 1400), Porto, Not set
MEMORIAL HEALTHCARE INTERNATIONAL S.R.L. ( Site 1703), Bucharest, Bucuresti
Spitalul Clinic Colțea ( Site 1708), București, Bucuresti
Cardiomed SRL Cluj-Napoca ( Site 1701), Cluj Napoca, Cluj
Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1702), Cluj Napoca, Cluj
S.C. Radiotherapy Center Cluj S.R.L ( Site 1706), Floresti, Cluj
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1704), Craiova, Dolj
Cabinet Medical Oncomed ( Site 1707), Timisoara, Timis
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0700), Hospitalet de Llobregat, Barcelona
HOSPITAL CLÍNIC DE BARCELONA ( Site 0707), Barcelona, Cataluna
Centro Oncologico de Galicia ( Site 0706), A Coruna, Galicia
Hospital General de Valencia ( Site 0703), Valencia, Valenciana, Comunitat
Hospital Universitari Vall d Hebron ( Site 0701), Barcelona, Not set
Hospital Ramon y Cajal ( Site 0705), Madrid, Not set
Hospital Virgen de la Victoria ( Site 0702), Malaga, Not set
Chang Gung Medical Foundation - Kaohsiung ( Site 1204), Kaohsiung, Not set
China Medical University Hospital ( Site 1205), Taichung, Not set
Taichung Veterans General Hospital ( Site 1206), Taichung, Not set
National Cheng Kung University Hospital ( Site 1202), Tainan, Not set
National Taiwan University Hospital ( Site 1200), Taipei, Not set
Taipei Veterans General Hospital ( Site 1201), Taipei, Not set
Chang Gung Memorial Hospital - Linkou Branch ( Site 1203), Taoyuan, Not set
Aberdeen Royal Infirmary ( Site 0911), Aberdeen, Aberdeen City
Castle Hill Hospital ( Site 0910), Cottingham, East Riding Of Yorkshire
The Beatson West of Scotland Cancer Centre ( Site 0909), Glasgow, Glasgow City
Guy s and St Thomas Hospital NHS Foundation Trust ( Site 0903), London, Great Britain
University Hospital Southampton NHS Foundation Trust ( Site 0905), Southampton, Hampshire
Royal Marsden Hospital ( Site 0902), London, London, City Of
Charing Cross Hospital ( Site 0908), London, London, City Of
Musgrove Park Hospital ( Site 0904), Taunton, Somerset
Royal Marsden Hospital. ( Site 0901), Sutton, Surrey
The Christie NHS Foundation Trust ( Site 0907), Manchester, Not set
Conditions: Squamous Cell Carcinoma of Head and Neck
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Recruiting
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates... Read More
The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physician's choice (TPC) (paclitaxel, nab-paclitaxel, carboplatin plus gemcitabine, and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen receptor (ER)-low, human epidermal growth factor receptor 2 (HER2)-negative BC patients who are not candidates for anti-PD(L)1 therapy and endocrine therapies. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Local Institution - 0303, Hot Springs, Arkansas +241 locations
Local Institution - 0303, Hot Springs, Arkansas
Local Institution - 0307, Cerritos, California
Local Institution - 0308, Cerritos, California
Local Institution - 0309, Cerritos, California
Local Institution - 0311, Long Beach, California
Local Institution - 0290, Los Angeles, California
Local Institution - 0283, Los Angeles, California
Local Institution - 0328, Whittier, California
Local Institution - 0289, Aurora, Colorado
Local Institution - 0304, Newark, Delaware
Local Institution - 0282, Miami, Florida
Local Institution - 0296, Pembroke Pines, Florida
Local Institution - 0294, Atlanta, Georgia
Local Institution - 0278, Chicago, Illinois
Local Institution - 0280, Chicago, Illinois
Decatur Memorial Hospital, Decatur, Illinois
Local Institution - 0324, O'Fallon, Illinois
Local Institution - 0286, Covington, Louisiana
Local Institution - 0288, Boston, Massachusetts
Local Institution - 0287, Boston, Massachusetts
Local Institution - 0313, Minneapolis, Minnesota
Local Institution - 0284, Kansas City, Missouri
Local Institution - 0312, New York, New York
Local Institution - 0279, New York, New York
Clinical Research Alliance, Westbury, New York
Local Institution - 0285, White Plains, New York
Local Institution - 0276, Durham, North Carolina
Local Institution - 0316, Eugene, Oregon
Local Institution - 0310, Philadelphia, Pennsylvania
Local Institution - 0281, Greenville, South Carolina
Local Institution - 0315, Austin, Texas
Local Institution - 0314, Houston, Texas
Local Institution - 0305, Tyler, Texas
Local Institution - 0277, Midlothian, Virginia
Local Institution - 0301, Roanoke, Virginia
Local Institution - 0302, Winchester, Virginia
Local Institution - 0345, Buenas Aires, Buenos Aires
Local Institution - 0011, Ciudad autónoma de Buenos Aires, Buenos Aires
Local Institution - 0214, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0143, Cordoba, Córdoba
Local Institution - 0137, Río Cuarto, Córdoba
Local Institution - 0142, Rosario, Santa Fe
Local Institution - 0317, Buenos Aires, Not set
Local Institution - 0346, Buenos Aires, Not set
Local Institution - 0012, Ciudad Autónoma de Buenos Aires, Not set
Local Institution - 0035, Brisbane, Queensland
Local Institution - 0197, Ballarat Central, Victoria
Local Institution - 0031, Heidelberg, Victoria
Local Institution - 0274, Melbourne, Victoria
Local Institution - 0028, Subiaco, Western Australia
Local Institution - 0292, Graz, Steiermark
Local Institution - 0268, Innsbruck, Tirol
Local Institution - 0267, Salzburg, Not set
Local Institution - 0270, St. Polten, Not set
Local Institution - 0269, Wien, Not set
Local Institution - 0187, Manaus, Amazonas
Local Institution - 0147, Fortaleza, Ceará
Local Institution - 0157, Vitória, Espírito Santo
Local Institution - 0199, Porto Alegre, Rio Grande Do Sul
Local Institution - 0164, São José do Rio Preto, São Paulo
Local Institution - 0153, Rio de Janeiro, Not set
Local Institution - 0144, São Paulo, Not set
Local Institution - 0149, São Paulo, Not set
Local Institution - 0218, Kelowna, British Columbia
Local Institution - 0217, Victoria, British Columbia
Local Institution - 0265, Ottawa, Ontario
Local Institution - 0215, Montréal, Quebec
Local Institution - 0219, Montréal, Quebec
Local Institution - 0350, Saint-Jerome, Quebec
Local Institution - 0216, Sherbrooke, Quebec
Local Institution - 0138, Santiago, Región Metropolitana De Santiago
Local Institution - 0021, Santiago, Región Metropolitana De Santiago
Local Institution - 0017, Santiago, Región Metropolitana De Santiago
Local Institution - 0018, Santiago, Región Metropolitana De Santiago
Local Institution - 0016, Viña del Mar, Valparaíso
Local Institution - 0195, Medellín, Antioquia
Local Institution - 0201, Rionegro, Antioquia
Local Institution - 0194, Barranquilla, Atlántico
Local Institution - 0182, Puerto Colombia, Atlántico
Local Institution - 0181, Montería, COR
Local Institution - 0327, Bogota, Cundinamarca
Local Institution - 0183, Cali, Valle Del Cauca
Local Institution - 0349, Medellin, Not set
Local Institution - 0089, Bordeaux, Aquitaine
Local Institution - 0272, Dijon, Côte-d'Or
Local Institution - 0098, Toulouse, Haute-Garonne
Local Institution - 0095, Montpellier, Hérault
Local Institution - 0099, Rennes, Ille-et-Vilaine
Local Institution - 0092, Saint Herblain, Loire-Atlantique
Local Institution - 0091, Reims, Marne
Local Institution - 0097, Villejuif, Paris
Local Institution - 0093, Marseille, Provence-Alpes-Côte-d'Azur
Local Institution - 0096, Clermont-Ferrand, Puy-de-Dôme
Local Institution - 0090, Lyon, Rhône-Alpes
Local Institution - 0094, Lille, Not set
Local Institution - 0088, Paris, Not set
Local Institution - 0320, Esslingen, Baden-Württemberg
Local Institution - 0256, Augsburg, Bayern
Local Institution - 0271, München, Bayern
Local Institution - 0306, Frankfurt, Hessen
Local Institution - 0333, Langen, Hessen
Local Institution - 0257, Hannover, Niedersachsen
Local Institution - 0293, Düsseldorf, Nordrhein-Westfalen
Local Institution - 0263, Essen, Nordrhein-Westfalen
Local Institution - 0254, Leipzig, Sachsen
Local Institution - 0255, Lübeck, Schleswig-Holstein
Local Institution - 0261, Berlin, Not set
Local Institution - 0260, Berlin, Not set
Local Institution - 0259, Bonn, Not set
Local Institution - 0258, Dresden, Not set
Local Institution - 0262, Heidelberg, Not set
Local Institution - 0291, Ulm, Not set
Local Institution - 0042, Athens, Attikí
Local Institution - 0038, Athens, Attikí
Local Institution - 0086, Heraklion, Irakleío
Local Institution - 0043, Athens, Not set
Local Institution - 0266, New Delhi, Delhi
Local Institution - 0206, New Delhi, Delhi
Local Institution - 0131, Mumbai, Maharashtra
Local Institution - 0134, Nagpur, Maharashtra
Local Institution - 0125, Chennai, Tamil Nadu
Local Institution - 0130, Hyderabad, Telangana
Local Institution - 0133, Varanasi, Uttar Pradesh
Local Institution - 0352, New Delhi, Not set
Local Institution - 0186, Petah Tikva, HaMerkaz
Local Institution - 0044, Ramat Gan, HaMerkaz
Local Institution - 0048, Hadera, HaTsafon
Local Institution - 0123, Haifa, HaTsafon
Local Institution - 0047, Jerusalem, Yerushalayim
Local Institution - 0051, Napoli, Campania
Local Institution - 0049, Bologna, Emilia-Romagna
Local Institution - 0057, Aviano, Friuli-Venezia Giulia
Local Institution - 0054, Genova, Liguria
Local Institution - 0053, Pontedera, Pisa
Local Institution - 0055, Prato, Toscana
Local Institution - 0052, Milano, Not set
Local Institution - 0058, Napoli, Not set
Local Institution - 0061, Novara, Not set
Local Institution - 0056, Padova, Not set
Local Institution - 0062, Roma, Not set
Local Institution - 0236, Nagoya, Aichi
Local Institution - 0230, Chiba-shi, Chiba
Local Institution - 0240, Matsuyama, Ehime
Local Institution - 0226, Otashi, Gunma
Local Institution - 0222, Sapporo, Hokkaido
Local Institution - 0232, Kanazawa, Ishikawa
Local Institution - 0234, Isehara, Kanagawa
Local Institution - 0237, Yokohama, Kanagawa
Local Institution - 0246, Tsu, Mie
Local Institution - 0223, Sendai-shi, Miyagi
Local Institution - 0238, Suita, Osaka
Local Institution - 0227, Hidaka, Saitama
Local Institution - 0224, Ina-machi, Saitama
Local Institution - 0231, Bunkyo-ku, Tokyo
Local Institution - 0229, Chuo-ku, Tokyo
Local Institution - 0228, Koto, Tokyo
Local Institution - 0245, Shinagawa, Tokyo
Local Institution - 0233, Shinjuku-ku, Tokyo
Local Institution - 0242, Fukuoka, Not set
Local Institution - 0225, Fukushima, Not set
Local Institution - 0243, Hiroshima, Not set
Local Institution - 0244, Kagoshima, Not set
Local Institution - 0235, Kyoto, Not set
Local Institution - 0241, Okayama, Not set
Local Institution - 0239, Osaka, Not set
Local Institution - 0066, Goyang-si, Kyǒnggi-do
Local Institution - 0067, Seongnam, Kyǒnggi-do
Local Institution - 0068, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0063, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0071, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0064, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0065, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0069, Daegu, Taegu-Kwangyǒkshi
Local Institution - 0264, Tijuana, Baja California
Local Institution - 0177, Mexico City, DIF
Local Institution - 0329, Mexico City, Distrito Federal
Local Institution - 0178, Guadalajara, Jalisco
Local Institution - 0175, Monterrey, Nuevo León
Local Institution - 0176, Monterrey, Nuevo León
Local Institution - 0173, Oaxaca de Juarez, Oaxaca
Local Institution - 0179, Merida, Yucatán
Local Institution - 0174, Chihuahua, Not set
Local Institution - 0074, Biala Podlaska, Lubelskie
Local Institution - 0072, Warszawa, Mazowieckie
Local Institution - 0220, Warszawa, Mazowieckie
Local Institution - 0076, Opole, Opolskie
Local Institution - 0189, Skórzewo, Wielkopolskie
Local Institution - 0221, Łódź, Łódzkie
Local Institution - 0198, Lisbon, Lisboa
Local Institution - 0106, Lisbon, Lisboa
Local Institution - 0109, Lisbon, Lisboa
Local Institution - 0124, Coimbra, Not set
Local Institution - 0141, Lisboa, Not set
Local Institution - 0111, Porto, Not set
Local Institution - 0253, Porto, Not set
Local Institution - 0212, Bistrita, Bistrița-Năsăud
Local Institution - 0213, Bucharest, București
Local Institution - 0079, Florești, Cluj
Local Institution - 0078, Craiova, Dolj
Local Institution - 0084, Ploiești, Prahova
Local Institution - 0211, Dumbravita, Timiș
Local Institution - 0085, Timișoara, Timiș
Local Institution - 0083, București, Not set
Local Institution - 0077, Cluj, Not set
Local Institution - 0081, Iași, Not set
Local Institution - 0080, Iași, Not set
Local Institution - 0351, East London, Eastern Cape
Local Institution - 0342, Parktown, Gauteng
Local Institution - 0336, Pretoria, Gauteng
Local Institution - 0341, Pretoria, Gauteng
Local Institution - 0340, Soweto, Gauteng
Local Institution - 0105, A Coruña, A Coruña [La Coruña]
Local Institution - 0100, Elche, Alicante
Local Institution - 0102, Barcelona, Barcelona [Barcelona]
Local Institution - 0172, Hospitalet, Barcelona [Barcelona]
Local Institution - 0140, Barcelona, Catalunya [Cataluña]
Local Institution - 0139, San Sebastian, Gipuzkoa
Local Institution - 0104, Madrid, Madrid, Comunidad De
Local Institution - 0108, Madrid, Madrid, Comunidad De
Local Institution - 0101, Malaga, Málaga
Local Institution - 0210, Valencia, Valenciana, Comunitat
Local Institution - 0107, Madrid, Not set
Local Institution - 0103, Sevilla, Not set
Local Institution - 0252, Malmö, Skåne Län [se-12]
Local Institution - 0026, Stockholm, Stockholms Län [se-01]
Local Institution - 0025, Uppsala, Uppsala Län [se-03]
Local Institution - 0024, Örebro, Örebro Län [se-18]
Local Institution - 0247, Linköping, Östergötlands Län [se-05]
Local Institution - 0250, st.Gallen, Sankt Gallen
Local Institution - 0249, Lausanne, Vaud
Local Institution - 0251, Zürich, Not set
Local Institution - 0323, Abu Dhabi, Abū Z̧aby
Local Institution - 0318, Abu Dhabi, Abū Z̧aby
Local Institution - 0322, Al Ain, Abū Z̧aby
Local Institution - 0319, Abu Dhabi, Not set
Local Institution - 0208, Truro, England
Local Institution - 0204, London, London, City Of
Local Institution - 0209, London, London, City Of
Local Institution - 0171, Belfast, Not set
Local Institution - 0004, London, Not set
Local Institution - 0001, Manchester, Not set
Local Institution - 0006, Nottingham, Not set
Conditions: Breast Neoplasms
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)
Active Not Recruiting
This study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration (Arms A and B) and in combination with pembrolizumab (Arm C). Dose expansion is to evaluate the objective response rate (ORR) of MK-4830 in combination with pembrolizumab (Arms A-F); evaluate the safety and tolerability of MK-4830 a... Read More
This study consists of several parts: dose escalation, dose expansion, dose expansion in Chinese participants residing in China, and coformulation. Dose escalation is to evaluate the safety, tolerability, and preliminary efficacy of MK-4830 monotherapy administration (Arms A and B) and in combination with pembrolizumab (Arm C). Dose expansion is to evaluate the objective response rate (ORR) of MK-4830 in combination with pembrolizumab (Arms A-F); evaluate the safety and tolerability of MK-4830 administered in combination with pembrolizumab, carboplatin, and pemetrexed (Arm G) and of MK-4830 administered in combination with pembrolizumab and lenvatinib (Arm H); evaluate the safety, tolerability and ORR of MK-4830 in combination with pembrolizumab plus chemotherapy (Arms I-L); and evaluate the safety and tolerability of MK-4830 in combination with pembrolizumab in Chinese participants from China (Arm M). The coformulation part (Arm N) evaluates the safety and tolerability of MK-4830A (coformulation of MK-4830 800 mg + pembrolizumab 200 mg). There is no formal hypothesis testing in this study. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: University of California at San Francisco ( Site 0004), San Francisco, California +36 locations
University of California at San Francisco ( Site 0004), San Francisco, California
Henry Ford Health System ( Site 0002), Detroit, Michigan
Washington University ( Site 0003), Saint Louis, Missouri
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005), Hackensack, New Jersey
Laura and Isaac Perlmutter Cancer Center ( Site 0008), New York, New York
Ohio State University Arthur G James Cancer Hospital & Richard J Solove Research Institute ( Site 00, Columbus, Ohio
South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas
Utah Cancer Specialists ( Site 0011), Salt Lake City, Utah
Seattle Cancer Care Alliance ( Site 0010), Seattle, Washington
Liverpool Hospital-Medical Oncology ( Site 0250), Liverpool, New South Wales
Princess Alexandra Hospital ( Site 0253), Brisbane, Queensland
Juravinski Cancer Centre ( Site 0034), Hamilton, Ontario
The Ottawa Hospital ( Site 0031), Ottawa, Ontario
Princess Margaret Cancer Centre ( Site 0033), Toronto, Ontario
The First Hospital of Jilin University ( Site 0803), Changchun, Jilin
Shanghai Chest Hospital-Oncology department ( Site 0801), Shanghai, Shanghai
West China Hospital of Sichuan University ( Site 0804), Chengdu, Sichuan
Hôpital Européen Georges Pompidou ( Site 2003), Paris, Ile-de-France
Centre Oscar Lambret ( Site 2002), Lille, Nord
Centre Hospitalier Universitaire de Poitiers ( Site 2000), Poitiers, Vienne
University General Hospital of Heraklion ( Site 0110), Heraklion, Irakleio
Euromedica General Clinic of Thessaloniki-Oncology Unit ( Site 0112), Thessaloniki, Not set
European Interbalkan Medical Center ( Site 0111), Thessaloniki, Not set
Rambam Health Care Campus-Oncology Division ( Site 0042), Haifa, Not set
Rabin Medical Center ( Site 0043), Petah Tikva, Not set
Chaim Sheba Medical Center. ( Site 0044), Ramat Gan, Not set
Sourasky Medical Center ( Site 0041), Tel Aviv, Not set
National Cancer Center Hospital East ( Site 0400), Kashiwa, Chiba
Japanese Foundation for Cancer Research ( Site 0401), Tokyo, Not set
Severance Hospital Yonsei University Health System ( Site 0300), Seoul, Not set
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie
Uniwersyteckie Centrum Kliniczne ( Site 0151), Gdansk, Pomorskie
Wits Clinical Research ( Site 0213), Johannesburg, Gauteng
The Oncology Centre ( Site 0212), Durban, Kwazulu-Natal
Cancercare Rondebosch Oncology ( Site 0210), Cape Town, Western Cape
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0101), Hospitalet de Llobregat, Barcelona
Centro Integral Oncologico Clara Campal START Madrid ( Site 0102), Madrid, Not set
Conditions: Neoplasms
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Active Not Recruiting
The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last up to 36 months (3 years) and possibly longer if the disease does not get worse.
The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-783. LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could last up to 36 months (3 years) and possibly longer if the disease does not get worse. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/22/2025
Locations: Mayo Clinic of Scottsdale, Scottsdale, Arizona +49 locations
Mayo Clinic of Scottsdale, Scottsdale, Arizona
UCLA Medical Center, Los Angeles, California
UCSF Medical Center at Mission Bay, San Francisco, California
Stanford University Hospital, Stanford, California
Mayo Clinic, Jacksonville, Florida
Winship Cancer Center Emory University, Atlanta, Georgia
Massachusetts General Hospital, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Mayo Clinic, Rochester, Minnesota
Washington University Medical School, Saint Louis, Missouri
Memorial Sloan Kettering Cancer Center, New York, New York
Wilmot Cancer Institute, Rochester, New York
Tennessee Oncology PLLC, Nashville, Tennessee
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas
UT Southwestern Medical Center, Dallas, Texas
University of Texas MD Anderson Cancer Center, Houston, Texas
South Texas Accelerated Research Therapeutics (START), San Antonio, Texas
St Vincent's Hospital, Sydney, New South Wales
Peter Maccallum Cancer Institute Erb, East Melbourne, Victoria
Cancer Research SA, Adelaide, Not set
Institut Jules Bordet, Anderlecht, Bruxelles-Capitale, Région De
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Not set
BC Cancer Vancouver, Vancouver, British Columbia
Princess Margaret Hospital (Hong Kong), Toronto, Ontario
Beijing Cancer hospital, Beijing, Beijing
The Third Hospital of Nanchang, Nanchang, Jiangxi
Fudan University Shanghai Cancer Center, Shanghai, Not set
Centre Leon Berard, Lyon CEDEX 08, Alpes
Institut de Cancérologie de l'Ouest, Saint Herblain, Loire-Atlantique
Institut Curie, Paris, Not set
ICANS_Institut de Cancerologie Strasbourg Europe, Strasbourg, Not set
Gustave Roussy, Villejuif, Not set
Universitätsklinikum Erlangen, Erlangen, Bayern
Aichi Cancer Center Hospital, Nagoya, Aichi
National Cancer Center Hospital, Chuo-ku, Tokyo
The Cancer Institute Hospital of JFCR, Koto City, Tokyo
Kyoto University Hospital, Kyoto, Not set
Samsung Medical Center, Seoul, Korea
Asan Medical Center, Seoul, Teukbyeolsi [Seoul]
National Cancer Centre Singapore, Singapore, Central Singapore
Hospital Quironsalud Madrid, Pozuelo de Alarcon, Madrid, Comunidad De
Hospital Clinico Universitario de Valencia, València, Valenciana, Comunitat
Hospital Universitario Quiron Dexeus, Barcelona, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Arnau de Vilanova Valencia, Valencia, Not set
Royal Marsden NHS Trust, London, Greater London
Royal Marsden Hospital (Sutton), Sutton, Surrey
Conditions: Breast Cancer
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Recruiting
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/21/2025
Locations: Palo Verde Hematology Oncology Ltd, Glendale, Arizona +226 locations
Palo Verde Hematology Oncology Ltd, Glendale, Arizona
California Cancer Associates for Research and Excellence, San Marcos, California
Texas Oncology, Santa Barbara, California
Innovative Clinical Research Institute, Whittier, California
Eastern CT Hematology and Oncology Associates, Norwich, Connecticut
George Washington Medical Faculty Associates, Washington, District of Columbia
Lake City Cancer Care, Lake City, Florida
Florida Cancer Specialists, Sarasota, Florida
Moffitt Cancer Center, Tampa, Florida
Peachtree Hematology Oncology Consultants, Atlanta, Georgia
Illinois Cancer Care, Peoria, Illinois
Messino Cancer Centers, Asheville, North Carolina
Oncology Hematology Care, Inc., Cincinnati, Ohio
Hematology & Oncology Associates, Eugene, Oregon
AHN Allegheny General Hospital, Pittsburgh, Pennsylvania
Arlington Cancer Center, Arlington, Texas
Texas Oncology - Austin, Austin, Texas
Texas Oncology, Dallas, Texas
Texas Oncology- Denison, Sherman, Texas
US Oncology Investigational Products Center (IPC), Arlington, Virginia
Oncology and Hematology Associates of Southwest Virginia, Inc, Blacksburg, Virginia
Northwest Cancer Specialists, PC, Vancouver, Washington
Investigaciones CORI S.R.L., Capital, Not set
Centro Médico Privado Centro de Especialidades Médicas Ambulatorias e Investigación Clínica, Cardoba, Not set
Centro Medico Barrio Parque, Ciudad Autanoma Buenos Aires, Not set
Sanatorio Allende, Cordoba, Not set
Sanatorio Britanico de Rosario, Rosario, Not set
Sanatorio Parque de Rosario, Rosario, Not set
Hospital Provincial del Centenario, Rosario, Not set
Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Not set
CAIPO - Centro para la Atención Integral del Paciente Oncológico, San Miguel de Tucumán, Not set
Clínica Viedma, Viedma, Not set
Klinikum Klagenfurt am Woerthersee, Klagenfurt Am Woerthersee, Not set
Ordensklinikum Linz GmbH, Elisabethinen, Linz, Not set
Klinikum Wels-Grieskirchen, Wels, Not set
Krankenhaus Nord - Klinik Floridsdorf, Wien, Not set
Algemeen Ziekenhuis Sint-Lucas, Aalst, Not set
Grand Hopital de Charleroi asbl (GHdC), Charleroi, Not set
AZ Sint-Maarten, Mechelen, Not set
CHU UCL Namur / Site Sainte Elisabeth, Namur, Not set
Cenantron Centro Avançado de Tratamento Oncologico Ltda, Belo Horizonte, Not set
Hospital Evangelico de Cachoeiro de Itapemirim, Cachoeiro De Itapemirim, Not set
Fundacao Universidade De Caxias Do Sul - FUCS/RS, Caxias Do Sul, Not set
Instituto do Câncer do Ceará - ICC, Fortaleza, Not set
Oncosite - Centro de Pesquisa Clinica em Oncologia LTDA, Ijui, Not set
Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Not set
Hospital de Clínicas de Porto Alegre, Porto Alegre, Not set
Hospital São Lucas da PUCRS, Porto Alegre, Not set
Hospital Ana Nery Santa Cruz do Sul, Santa Cruz Do Sul, Not set
Centro Des Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho, Sao Paolo, Not set
Instituto Brasiliero de Controle do Cancer IBCC, Sao Paulo, Not set
Centre Integre de sante et de services sociaux de la Monteregie Centre, Greenfield Park, Not set
Moncton Hospital, Moncton, Not set
CISSS des Laurentides, Quebec, Not set
Centre de santé et services sociaux de Rimouski-Neigette, Rimouski, Not set
BC Cancer - Victoria, Victoria, Not set
Clinica Alemana de Santiago, Las Condes, Not set
Orlandioncologia, Providencia, Not set
Oncovida- Santiago, Providencia, Not set
Clinica Puerto Montt, Puerto Montt, Not set
Biocinetic, Santiago, Not set
James Lind Centro de Investigacion del Cancer, Temuco, Not set
Oncocentro APYS, Vina del Mar, Not set
West China Hospital Sichuan University, Chengdu, Not set
Chongqing University Cancer Hospital, Chongqing, Not set
Deyang People's Hospital, Deyang, Not set
Fujian Cancer Hospital, Fuzhou, Not set
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Not set
Guangzhou First People's Hospital, Guangzhou, Not set
Nanfang Hospital, Southern Medical University, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou, Not set
Anhui Chest Hospital, Hefei, Not set
The Second Affiliated Hospital of Nanchang University, Jiangxi, Not set
Shandong Cancer Hospital, Jinan, Not set
Jiangxi Chest Hospital, Nanchang, Not set
Nanjing Drum Tower Hospital, Nanjing, Not set
Guangxi Medical University Cancer Hospital, Nanning, Not set
Shanghai Chest Hospital, Shanghai, Not set
Shanghai East Hospital, Shanghai, Not set
Shanghai Pulmonary Hospital, Shanghai, Not set
Cancer Hospital of Shantou University Medical College, Shantou, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Not set
Tongji Hospital Tongji Medical College of Hust, Wuhan, Not set
The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Not set
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Not set
Henan Cancer Hospital, Zhengzhou, Not set
Ambroise-Pare Hospital, Assistance Publique - Hopitaux de Paris, Boulogne-Billancourt, Not set
CHU de Caen, Caen, Not set
Clinique Victor Hugo, Centre de Cancerologie de la Sarthe, Le Mans, Not set
Hopital Nord, Marseille, Not set
Institut de Cancer de Montpellier (ICM) - Val d'Aurelle, Montpellier, Not set
Centre Antoine Lacassagne, Nice, Not set
Institut de cancerologie de l'ouest (ICO), Saint-Herblain, Not set
Hopital d'Instruction des Armees (HIA) Begin, Saint-Mandé, Not set
Centre Hospitalier de Saint-Quentin, Saint-Quentin, Not set
Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, Not set
Hôpital Foch, Suresnes, Not set
CHI de Toulon la Seyne-sur-Mer Hopital Sainte Musse, Toulon cedex, Not set
Augusta-Kranken-Anstalt gGmbh Klinik für Hämatologie Onkologie und Palliativmedizin, Bochum, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
Universitatsklinikum Essen / Westdeutsches Tumorzentrum, Innere Klinik (Tumorforschung), Essen, Not set
Universitätsklinikum Freiburg, Klinik für Innere Medizin I Hämatologie, Onkologie und Stammzelltransplantation, Freiburg, Not set
LungenClinic Grosshansdorf, Grosshansdorf, Not set
Krankenhaus Martha-Maria Halle Dölau, Halle, Not set
Asklepios Kliniken Hamburg, Hamburg, Not set
Katholisches Marienkrankenhaus gGmbH, Hamburg, Not set
Lungenklinik Hemer, Zentrum fur Pneumologie and Thoraxchirurgie, Hemer, Not set
Vincentius-Diakonissen-Kliniken gAG, St. Vincentius-Kliniken, Medizinische Klinik 2, Karlsruhe, Not set
Klinikum Kassel, Kassel, Not set
Kliniken der Stadt Köln ggmbh, Krankenhaus Koln-Merheim/Lungenklinik, Köln, Not set
Universitatsklinikum Schleswig-Holstein, Lubeck, Not set
Johannes Wesling Klinikum Minden, Minden, Not set
Munchen Klinik Bogenhausen, Klinik fur Pneumologie und Pneumologische Onkologie, Munchen, Not set
Sana Klinikum Offenbach GmbH, Medizinische Klinik IV, Hämatologie und Internistische Onkologie, Offenbach, Not set
Queen Elizabeth Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Prince of Wales Hospital, New Territories, Not set
Soroka University Medical Center, Itzchak Rager Blvd., Beer Seva, Not set
Shaare Zedek Medical Center, Jerusalem, Not set
Oncology Institute, Galilee Medical Center, Route 89 Nahariya-Cabri, Nahariya, Not set
Rabin Medical Center, Petah Tiqva, Not set
Kaplan Medical Center, Rehovot, Not set
Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set
Azienda Ospedaliera San Giuseppe Moscati, Avellino, Not set
IRCCS Fondazoine del Piemonte per l'Oncologia, Candiolo, Not set
Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Not set
Ospedale Policlinico San Martino, Genova, Not set
Ospedale San Raffaele, Milano, Not set
Azienda Ospedaliero Universitaria di Modena, Modena, Not set
AORN Cardarelli, Naples, Not set
Azienda Ospedaliera dei Colli, Napoli, Not set
IRCCS Policlinico S. Matteo, Dipartimento Oncologia Ematologia-Oncologia Medica, Pavia, Not set
Azienda Sanitaria Territoriale Pesaro e Urbino (AST), Pesaro, Not set
Ospedale Guglielmo da Saliceto AUSL di Piacenza, Piacenza, Not set
Centro di Riferimento Oncologico, Pordenone, Not set
Regina Elena Institute for Cancer Research, Rome, Not set
ASST Bergamo Ovest- ospedale di Treviglio, Treviglio, Not set
National Cancer Center Hospital East, Chiba, Not set
National Hospital Organization Shikoku Cancer Center, Ehime, Not set
Kyushu University Hospital, Fukuoka, Not set
Kurume University Hospital, Fukuoka, Not set
National Hospital Organization Himeji Medical Center, Hyogo, Not set
Hyogo Cancer Center, Hyogo, Not set
Kanazawa University Hospital, Ishikawa, Not set
Kanagawa Cancer Center, Kanagawa, Not set
Sendai Kousei Hospital, Miyagi, Not set
Niigata Cancer Center Hospital, Niigata, Not set
Osaka Metropolitan University Hospital, Osaka, Not set
Osaka Medical and Pharmaceutical University Hospital, Osaka, Not set
Kindai University Hospital, Osaka, Not set
National Hospital Organization Kinki Chuo Chest Medical Center, Osaka, Not set
Saitama Medical University, Saitama, Not set
SMG - SNU Boramae Medical Center, Dongjak-Gu, Not set
Samsung Medical Center, Gangnam-Gu, Not set
National Cancer Center, Goyang, Not set
Chungbuk National University Hospital, Heungdeok-Gu, Not set
Inha University Hospital, Incheon, Not set
Gachon University Gil Medical Center, Inchon, Not set
Kosin University Gospel Hospital, Seo-gu, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set
Ajou University Hospital, Suwon-si, Not set
The Catholic University of Korea, Saint Vincent's Hospital, Suwon, Not set
Health Pharma Professional Research S.A. de C.V., Mexico, Not set
Hospital Universitario Dr. Jose Eleuterio Gonzalez, Mitras Centro, Not set
Oaxaca Site Management Organization, Oaxaca, Not set
Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set
Clinical Medical Research SC., Orizaba Centro, Not set
Clinica Integral Internacional de Oncologia S de RL de CV, Puebla, Not set
FAICIC Clínical Research, Veracruz, Not set
Amphia Ziekenhuis, Breda, Not set
Ziekenhuis Gelderse Vallei, Ede, Not set
Universitair Medisch Centrum Groningen, Groningen, Not set
Ziekenhuis St Jansdal, Harderwijk, Not set
TweeSteden Ziekenhuis, Tilburg, Not set
Hospital Prof. Doutor Fernando Fonseca, Amadora, Not set
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Not set
Fundacao Champalimaud, Lisboa, Not set
Centro Hospitalar Universitário Lisboa Norte - Hospital Pulido Valente, Lisboa, Not set
Hospital Beatriz Angelo. Hospital de Loures., Lisbon, Not set
Centro Hospitalar Universitario Sao Joao, EPE, Porto, Not set
Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Senhora da Hora, Not set
Raffles Hospital, Singapore, Not set
Tang Tock Seng Hospital, Singapore, Not set
Hospital Clinic de Barcelona, Barcelona, Not set
Hospital de la Santa Creu i de Sant Pau, Barcelona, Not set
Hospital Universitari Dexeus (USP Institut Universitari Dexeus/Hospital Universitari Quiron Dexeus), Barcelona, Not set
Hospital Universitari Vall D'Hebron, Barcelona, Not set
Hospital Parc Tauli, Barcelona, Not set
Hospital Universitario Reina Sofia, Cordoba, Not set
Hospital Doctor Josep Trueta, Girona, Not set
Hospital Universitario de Jaen, Jaen, Not set
Hospital Universitario de Canarias, Las Palmas de G.C., Not set
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Clinica Universidad de Navarra, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set
Hospital Sant Joan de Reus, Reus, Not set
Hospital Regional Universitario de Malaga, Rincon de la Victoria, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
Hospital Universitario Virgen del Rocio, Seville, Not set
Instituto Valenciano De Oncologia (IVO), Valencia, Not set
Hospital Universitari i Politecnic La Fe, Valencia, Not set
Hospital Vithas Valencia 9 de Octubre, Valencia, Not set
Changhua Christian Hospital, Changhua City, Not set
E-DA Hospital, Kaohsiung City, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
Chang Gung Memorial Hospital Kaohsiung, Kaohsiung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Chi Mei Hospital, Liouying, Tainan, Not set
National Taiwan University Hospital, Taipei City, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Memorial Hospital Linkou Branch of the Chang Gung Medical Foundation, Taoyuan City, Not set
Ankara Bilkent Sehir Hastanesi, Ankara, Not set
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Not set
Trakya University Faculty of Medicine, Edirne, Not set
Istanbul University Cerrahpasa Medical Faculty Hospital, Fatih, Not set
Goztepe Prof. Dr. Suleyman Yalcın Sehir Hastanesi, Istanbul, Not set
Medipol Mega University Hospital, Istanbul, Not set
Acibadem Mehmet Ali Aydinlar Universitesi Atakent Hastanesi, Kaakaekmece, Not set
Turgut Ozal Medical Faculty, Malatya, Not set
Colchester General Hospital, Colchester, Not set
St Bartholomew's Hospital, Barts Health NHS Trust, London, Not set
The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, Not set
University Hospital Southampton Nhs Foundation Trust, Southampton, Not set
Conditions: Non-small Cell Lung Cancer
13 - 24 of 342